<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 750px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             
             #loadingBar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width: 100%;
                 height: 750px;
                 background-color:rgba(200,200,200,0.8);
                 -webkit-transition: all 0.5s ease;
                 -moz-transition: all 0.5s ease;
                 -ms-transition: all 0.5s ease;
                 -o-transition: all 0.5s ease;
                 transition: all 0.5s ease;
                 opacity:1;
             }

             #bar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width:20px;
                 height:20px;
                 margin:auto auto auto auto;
                 border-radius:11px;
                 border:2px solid rgba(30,30,30,0.05);
                 background: rgb(0, 173, 246); /* Old browsers */
                 box-shadow: 2px 0px 4px rgba(0,0,0,0.4);
             }

             #border {
                 position:absolute;
                 top:10px;
                 left:10px;
                 width:500px;
                 height:23px;
                 margin:auto auto auto auto;
                 box-shadow: 0px 0px 4px rgba(0,0,0,0.2);
                 border-radius:10px;
             }

             #text {
                 position:absolute;
                 top:8px;
                 left:530px;
                 width:30px;
                 height:50px;
                 margin:auto auto auto auto;
                 font-size:22px;
                 color: #000000;
             }

             div.outerBorder {
                 position:relative;
                 top:400px;
                 width:600px;
                 height:44px;
                 margin:auto auto auto auto;
                 border:8px solid rgba(0,0,0,0.1);
                 background: rgb(252,252,252); /* Old browsers */
                 background: -moz-linear-gradient(top,  rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */
                 background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */
                 background: -webkit-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */
                 background: -o-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */
                 background: -ms-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */
                 background: linear-gradient(to bottom,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */
                 filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */
                 border-radius:72px;
                 box-shadow: 0px 0px 10px rgba(0,0,0,0.2);
             }
             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
            <div id="loadingBar">
              <div class="outerBorder">
                <div id="text">0%</div>
                <div id="border">
                  <div id="bar"></div>
                </div>
              </div>
            </div>
        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "label": "A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CARCINOEMBRYONIC ANTIGEN (CEA)", "label": "CARCINOEMBRYONIC ANTIGEN (CEA)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CANCER ANTIGEN 125 (CA125)", "label": "CANCER ANTIGEN 125 (CA125)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA125-II", "label": "CA125-II", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HE4 (HUMAN EPIDIDYMIS PROTEIN 4)", "label": "HE4 (HUMAN EPIDIDYMIS PROTEIN 4)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRANSFERRIN", "label": "TRANSFERRIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BETA-2-MICROGLOBULIN", "label": "BETA-2-MICROGLOBULIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOLIPOPROTEIN A-1", "label": "APOLIPOPROTEIN A-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRANSTHYRETIN", "label": "TRANSTHYRETIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FOLLICLE-STIMULATING HORMONE", "label": "FOLLICLE-STIMULATING HORMONE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LACTATE DEHYDROGENASE (LDH)", "label": "LACTATE DEHYDROGENASE (LDH)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BETA-HCG", "label": "BETA-HCG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::INHIBIN B", "label": "INHIBIN B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALPHA-FETOPROTEIN", "label": "ALPHA-FETOPROTEIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "label": "A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA-125", "label": "CA-125", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HE4", "label": "HE4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OSTEOPONTIN", "label": "OSTEOPONTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OPN", "label": "OPN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "label": "AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AHRR", "label": "AHRR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PPP1R3C", "label": "PPP1R3C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AHR", "label": "AHR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGFD", "label": "VEGFD", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CYTOCHROME P450", "label": "CYTOCHROME P450", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::RAD51 as a Biomarker for Homologous Recombination Deficiency in High\u2010Grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 test", "label": "RAD51 as a Biomarker for Homologous Recombination Deficiency in High\u2010Grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 test", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RAD51", "label": "RAD51", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::\u0393H2AX", "label": "\u0393H2AX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GEMININ", "label": "GEMININ", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::nan", "label": "nan", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NF-\u039aB", "label": "NF-\u039aB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGF-A", "label": "VEGF-A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGF-\u03921", "label": "TGF-\u03921", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKC", "label": "PKC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BETA-CATENIN", "label": "BETA-CATENIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "label": "RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KI-67", "label": "KI-67", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AURKB", "label": "AURKB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P53", "label": "P53", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA125", "label": "CA125", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "label": "Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BECLIN-1", "label": "BECLIN-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LC3", "label": "LC3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BCL-2", "label": "BCL-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BCL-XL", "label": "BCL-XL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BAX", "label": "BAX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BAD", "label": "BAD", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CASPASE-3", "label": "CASPASE-3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CASPASE-8", "label": "CASPASE-8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CASPASE-9", "label": "CASPASE-9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AMPK", "label": "AMPK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKC\u0392", "label": "PKC\u0392", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AKT", "label": "AKT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MTOR", "label": "MTOR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ERBB2", "label": "ERBB2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EGFR", "label": "EGFR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ERBB3", "label": "ERBB3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HSP90", "label": "HSP90", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGF", "label": "VEGF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGFR", "label": "VEGFR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PDGFR", "label": "PDGFR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KDR", "label": "KDR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-6", "label": "IL-6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL6R", "label": "IL6R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GP130", "label": "GP130", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RIPK3", "label": "RIPK3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MLKL", "label": "MLKL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD44", "label": "CD44", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MUC16", "label": "MUC16", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP3", "label": "MMP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RAF-1", "label": "RAF-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P62", "label": "P62", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LKB1", "label": "LKB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SIRT3", "label": "SIRT3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALDH", "label": "ALDH", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GSK3\u0392", "label": "GSK3\u0392", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ERK", "label": "ERK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P38 MAPK", "label": "P38 MAPK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::JAK1", "label": "JAK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::JAK2", "label": "JAK2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::STAT3", "label": "STAT3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "label": "Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EGF", "label": "EGF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MAPK", "label": "MAPK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PI3K", "label": "PI3K", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HIF1\u0391", "label": "HIF1\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HDAC3", "label": "HDAC3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::JAK", "label": "JAK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PD-L1", "label": "PD-L1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PD-1", "label": "PD-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-8", "label": "IL-8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-1\u0391", "label": "IL-1\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ANXA2", "label": "ANXA2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD147", "label": "CD147", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP-2", "label": "MMP-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP-9", "label": "MMP-9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::E-CADHERIN", "label": "E-CADHERIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::N-CADHERIN", "label": "N-CADHERIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SNAIL", "label": "SNAIL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CLEAVED CASPASE-3", "label": "CLEAVED CASPASE-3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DUSP6", "label": "DUSP6", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "label": "Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MESOTHELIN", "label": "MESOTHELIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EGR1", "label": "EGR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NF-KB", "label": "NF-KB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BIM", "label": "BIM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CTLA-4", "label": "CTLA-4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MHC-I", "label": "MHC-I", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OX40L", "label": "OX40L", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OX40", "label": "OX40", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::4-1BBL", "label": "4-1BBL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::4-1BB", "label": "4-1BB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DR4", "label": "DR4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGFR1", "label": "VEGFR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TROP-2", "label": "TROP-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MAGE-A3", "label": "MAGE-A3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MAGE-A6", "label": "MAGE-A6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SPD-1", "label": "SPD-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SPD-L1", "label": "SPD-L1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IFN-\u0393", "label": "IFN-\u0393", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LEPTIN", "label": "LEPTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FIBRINOGEN", "label": "FIBRINOGEN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LDH", "label": "LDH", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ARGONAUTE2", "label": "ARGONAUTE2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD81", "label": "CD81", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HDACS", "label": "HDACS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SIRT1", "label": "SIRT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PARP1", "label": "PARP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "label": "Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MSLN", "label": "MSLN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FOLR1", "label": "FOLR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA72.4", "label": "CA72.4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EPCAM", "label": "EPCAM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD117", "label": "CD117", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HARS", "label": "HARS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RO52", "label": "RO52", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CDR2", "label": "CDR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::4H4", "label": "4H4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::5H6", "label": "5H6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KI67", "label": "KI67", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "label": "Role of different non-coding RNAs as ovarian Cancer biomarkers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PARP", "label": "PARP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AGO1", "label": "AGO1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AGO2", "label": "AGO2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AGO3", "label": "AGO3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AGO4", "label": "AGO4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PIWIL1", "label": "PIWIL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PIWIL2", "label": "PIWIL2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PIWIL3", "label": "PIWIL3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PIWIL4", "label": "PIWIL4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::YAP1", "label": "YAP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "label": "Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SMAD4", "label": "SMAD4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MTA3", "label": "MTA3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP9", "label": "MMP9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VIMENTIN", "label": "VIMENTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IASPP", "label": "IASPP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MEK1", "label": "MEK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ERK1", "label": "ERK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::JNK1", "label": "JNK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGF\u03921", "label": "TGF\u03921", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BAK", "label": "BAK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SRPK1", "label": "SRPK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP14", "label": "MMP14", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BMI1", "label": "BMI1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BCL2", "label": "BCL2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TIMP1", "label": "TIMP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ZEB1", "label": "ZEB1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "label": "Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PTEN", "label": "PTEN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VIM", "label": "VIM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ZO-1", "label": "ZO-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BCL10", "label": "BCL10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BCL2L1", "label": "BCL2L1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCL1", "label": "CXCL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCL8", "label": "CXCL8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ER\u0391", "label": "ER\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::S1PR1", "label": "S1PR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HK2", "label": "HK2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TAK1", "label": "TAK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MAP3K7", "label": "MAP3K7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HIF1A", "label": "HIF1A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EPAS1", "label": "EPAS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TNF", "label": "TNF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IRAK1", "label": "IRAK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRAF6", "label": "TRAF6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PIK3CA", "label": "PIK3CA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PIK3CB", "label": "PIK3CB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AKT1", "label": "AKT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ABCB1", "label": "ABCB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GSTP1", "label": "GSTP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NAV3", "label": "NAV3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ITGA5", "label": "ITGA5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PCDH9", "label": "PCDH9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RUNX2", "label": "RUNX2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CHD4", "label": "CHD4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HNRNPC", "label": "HNRNPC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NFIX", "label": "NFIX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DICER", "label": "DICER", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DGCR8", "label": "DGCR8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::XPO5", "label": "XPO5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RAN", "label": "RAN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TARBP2", "label": "TARBP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PRKRA", "label": "PRKRA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLF6", "label": "KLF6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLF12", "label": "KLF12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SP1", "label": "SP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FBXL10", "label": "FBXL10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::XIAP", "label": "XIAP", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "label": "Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HER2", "label": "HER2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MUC1", "label": "MUC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::WT1", "label": "WT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PAX8", "label": "PAX8", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas", "label": "Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BRCA1 PROTEIN", "label": "BRCA1 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BRCA2 PROTEIN", "label": "BRCA2 PROTEIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "label": "SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SLC11A2 PROTEIN", "label": "SLC11A2 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::\u0392-ACTIN", "label": "\u0392-ACTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ANNEXIN V", "label": "ANNEXIN V", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "label": "SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SPON1", "label": "SPON1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::F-SPONDIN", "label": "F-SPONDIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AMYLOID-\u0392 PRECURSOR PROTEIN (APP)", "label": "AMYLOID-\u0392 PRECURSOR PROTEIN (APP)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALPHA-SMOOTH MUSCLE ACTIN (\u0391SMA)", "label": "ALPHA-SMOOTH MUSCLE ACTIN (\u0391SMA)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CYTOKERATIN", "label": "CYTOKERATIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAMTS1", "label": "ADAMTS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAMTS5", "label": "ADAMTS5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAMTS13", "label": "ADAMTS13", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAMTS-LIKE PROTEIN", "label": "ADAMTS-LIKE PROTEIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "label": "SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SUGT1", "label": "SUGT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SCRIBBLES", "label": "SCRIBBLES", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PAX3-FOXO1", "label": "PAX3-FOXO1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EWS-FLI1", "label": "EWS-FLI1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SCF-\u0392-TRCP", "label": "SCF-\u0392-TRCP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL6", "label": "IL6", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "label": "Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HEPCIDIN", "label": "HEPCIDIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FERROPORTIN", "label": "FERROPORTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MAGP-2", "label": "MAGP-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA19-9", "label": "CA19-9", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum CA125, CA199 and CEA combined detection \r\nfor epithelial ovarian cancer diagnosis: A meta\r\nanalysis", "label": "Serum CA125, CA199 and CEA combined detection \r\nfor epithelial ovarian cancer diagnosis: A meta\r\nanalysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CEA", "label": "CEA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "label": "Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-7", "label": "IL-7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-10", "label": "IL-10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::G-CSF", "label": "G-CSF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GM-CSF", "label": "GM-CSF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TNF-\u0391", "label": "TNF-\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-5", "label": "IL-5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-12P70", "label": "IL-12P70", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-13", "label": "IL-13", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-15", "label": "IL-15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-17", "label": "IL-17", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MCP-1", "label": "MCP-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IP-10", "label": "IP-10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EOTAXIN", "label": "EOTAXIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MIP-1\u0391", "label": "MIP-1\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-4", "label": "IL-4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-2", "label": "IL-2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "label": "Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LRP1", "label": "LRP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP2", "label": "MMP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P-ERK", "label": "P-ERK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GAPDH", "label": "GAPDH", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD9", "label": "CD9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD63", "label": "CD63", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TSG101", "label": "TSG101", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FN1", "label": "FN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOA4", "label": "APOA4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VWF", "label": "VWF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOM", "label": "APOM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C1R", "label": "C1R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOC1", "label": "APOC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SPP2", "label": "SPP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOD", "label": "APOD", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FCN3", "label": "FCN3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "label": "Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CFL1", "label": "CFL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EZR", "label": "EZR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CYPA", "label": "CYPA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PFN1", "label": "PFN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NAPSA", "label": "NAPSA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "label": "Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA242", "label": "CA242", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AFP", "label": "AFP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::\u0392-HCG", "label": "\u0392-HCG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA199", "label": "CA199", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NSE", "label": "NSE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FERRITIN", "label": "FERRITIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA153", "label": "CA153", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HGH", "label": "HGH", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "label": "Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HIF-1\u0391", "label": "HIF-1\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CK8", "label": "CK8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CK18", "label": "CK18", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CK19", "label": "CK19", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD45", "label": "CD45", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Shortcomings in the evaluation of biomarkers \r\nin ovarian cancer: a systematic review", "label": "Shortcomings in the evaluation of biomarkers \r\nin ovarian cancer: a systematic review", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::CancerAntigen125LevelsatTimeofOvarianCancerDiagnosis\r\n byRaceandEthnicity", "label": "CancerAntigen125LevelsatTimeofOvarianCancerDiagnosis\r\n byRaceandEthnicity", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MUC-16", "label": "MUC-16", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "label": "The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOLIPOPROTEIN A1", "label": "APOLIPOPROTEIN A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP-7", "label": "MMP-7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PROSTASIN", "label": "PROSTASIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLK6", "label": "KLK6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLK7", "label": "KLK7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLK9", "label": "KLK9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MDK", "label": "MDK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PROS1", "label": "PROS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SLPI", "label": "SLPI", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IGFBP2", "label": "IGFBP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IGFBP3", "label": "IGFBP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GRN", "label": "GRN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RARRES2", "label": "RARRES2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD14", "label": "CD14", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA72-4", "label": "CA72-4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA15-3", "label": "CA15-3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::B7-H4", "label": "B7-H4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CTLA4", "label": "CTLA4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CYTOKERATINS", "label": "CYTOKERATINS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ESTROGEN RECEPTOR", "label": "ESTROGEN RECEPTOR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PROGESTERONE RECEPTOR", "label": "PROGESTERONE RECEPTOR", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "label": "The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KALLIKREINS", "label": "KALLIKREINS", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "label": "The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMPS", "label": "MMPS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P38", "label": "P38", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::JNK", "label": "JNK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AP-1", "label": "AP-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C-JUN", "label": "C-JUN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FOS", "label": "FOS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD16", "label": "CD16", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FC\u0393RIII", "label": "FC\u0393RIII", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::E4", "label": "E4", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "label": "The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TP53", "label": "TP53", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CTIP", "label": "CTIP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MRE11", "label": "MRE11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RAD50", "label": "RAD50", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NBS1", "label": "NBS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::H2AX", "label": "H2AX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RPA", "label": "RPA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RAD52", "label": "RAD52", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "label": "The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LIF", "label": "LIF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGF-\u0392", "label": "TGF-\u0392", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-12", "label": "IL-12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CCL18", "label": "CCL18", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CCL22", "label": "CCL22", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CCL20", "label": "CCL20", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGF-C", "label": "VEGF-C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ICAM-1", "label": "ICAM-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD163", "label": "CD163", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD206", "label": "CD206", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD68", "label": "CD68", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD86", "label": "CD86", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::STAT6", "label": "STAT6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IRF4", "label": "IRF4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PPAR-\u0393", "label": "PPAR-\u0393", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CSF-1", "label": "CSF-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CSF-1R", "label": "CSF-1R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SOCS3", "label": "SOCS3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IGF-1", "label": "IGF-1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "label": "The biological significance and clinical applications of exosomes in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALIX", "label": "ALIX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD37", "label": "CD37", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD53", "label": "CD53", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD82", "label": "CD82", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HSP84", "label": "HSP84", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::90", "label": "90", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HSC70", "label": "HSC70", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MHC I", "label": "MHC I", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MHC II", "label": "MHC II", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PHOSPHATE ISOMERASE", "label": "PHOSPHATE ISOMERASE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PEROXIREDOXIN", "label": "PEROXIREDOXIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALDEHYDE REDUCTASE", "label": "ALDEHYDE REDUCTASE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FATTY ACID SYNTHASE", "label": "FATTY ACID SYNTHASE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ANNEXIN A3", "label": "ANNEXIN A3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ANNEXIN A2", "label": "ANNEXIN A2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD44V6", "label": "CD44V6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD105", "label": "CD105", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::L1CAM", "label": "L1CAM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAM10", "label": "ADAM10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EMMPRIN", "label": "EMMPRIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD24", "label": "CD24", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RAB27A", "label": "RAB27A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FLOTILLIN2", "label": "FLOTILLIN2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HSP70", "label": "HSP70", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::WNT", "label": "WNT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGF\u0392", "label": "TGF\u0392", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TNF\u0391", "label": "TNF\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ILK1", "label": "ILK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::\u0392-CATENIN", "label": "\u0392-CATENIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HEPATOMA-DERIVED GROWTH FACTOR", "label": "HEPATOMA-DERIVED GROWTH FACTOR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CASEIN KINASE II", "label": "CASEIN KINASE II", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::INTEGRIN 3", "label": "INTEGRIN 3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CAVEOLIN-1", "label": "CAVEOLIN-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HNRNPA2B1", "label": "HNRNPA2B1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RISC", "label": "RISC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DROSHA", "label": "DROSHA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RNA POLYMERASE II", "label": "RNA POLYMERASE II", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "label": "The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GZMB", "label": "GZMB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD8", "label": "CD8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCR5", "label": "CXCR5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGFR3", "label": "VEGFR3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCL9", "label": "CXCL9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCL11", "label": "CXCL11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCL13", "label": "CXCL13", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "label": "Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BETA-2-MACROGLOBULIN", "label": "BETA-2-MACROGLOBULIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOLIPOPROTEIN A4", "label": "APOLIPOPROTEIN A4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOLIPOPROTEIN E", "label": "APOLIPOPROTEIN E", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NITRIC OXIDE SYNTHASE", "label": "NITRIC OXIDE SYNTHASE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CYCLOOXYGENASE-2", "label": "CYCLOOXYGENASE-2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "label": "Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C5A", "label": "C5A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C5AR1", "label": "C5AR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C5AR", "label": "C5AR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::2", "label": "2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis", "label": "The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BEVACIZUMAB", "label": "BEVACIZUMAB", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "label": "The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GALECTIN-1", "label": "GALECTIN-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GALECTIN-3", "label": "GALECTIN-3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GALECTIN-7", "label": "GALECTIN-7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GALECTIN-8", "label": "GALECTIN-8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GALECTIN-9", "label": "GALECTIN-9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NF-\u039aB (P65)", "label": "NF-\u039aB (P65)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P21", "label": "P21", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HRAS", "label": "HRAS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MEK", "label": "MEK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD71", "label": "CD71", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD95", "label": "CD95", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FAS", "label": "FAS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BFGF", "label": "BFGF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MYD88", "label": "MYD88", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CAV-1", "label": "CAV-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TLR4", "label": "TLR4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GPIB", "label": "GPIB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::COL4A1", "label": "COL4A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD166", "label": "CD166", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NOTCH1", "label": "NOTCH1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KRAS", "label": "KRAS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P-STAT3", "label": "P-STAT3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "label": "The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PROLACTIN", "label": "PROLACTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IGF-II", "label": "IGF-II", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MIF", "label": "MIF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EOTAXIN-1", "label": "EOTAXIN-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CVCAM", "label": "CVCAM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-2R ALPHA", "label": "IL-2R ALPHA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::M-CSF", "label": "M-CSF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::INTER-ALPHA-TRYPSIN INHIBITOR HEAVY CHAIN H4", "label": "INTER-ALPHA-TRYPSIN INHIBITOR HEAVY CHAIN H4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::B2-MICROGLOBULIN", "label": "B2-MICROGLOBULIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SMRP", "label": "SMRP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALDH1", "label": "ALDH1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "label": "Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TAAR1", "label": "TAAR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ER-\u0391", "label": "ER-\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ER-\u0392", "label": "ER-\u0392", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PR-A", "label": "PR-A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PR-B", "label": "PR-B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GPER", "label": "GPER", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GPR30", "label": "GPR30", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GLYCODELINA", "label": "GLYCODELINA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ODC", "label": "ODC", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "label": "Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MSN", "label": "MSN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KRT19", "label": "KRT19", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KRT7", "label": "KRT7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::JUNB", "label": "JUNB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::COL5A2", "label": "COL5A2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::COL1A2", "label": "COL1A2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BMP5", "label": "BMP5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::F10", "label": "F10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BMP4", "label": "BMP4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP1", "label": "MMP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLK4", "label": "KLK4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLK5", "label": "KLK5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RDX", "label": "RDX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGF\u0392-1", "label": "TGF\u0392-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALK1", "label": "ALK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BMP9", "label": "BMP9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BMP10", "label": "BMP10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CYFRA 21-1", "label": "CYFRA 21-1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "label": "ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ZNF76", "label": "ZNF76", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TATA-BINDING PROTEIN", "label": "TATA-BINDING PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::STAF", "label": "STAF", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Increased circulating tumor DNA as a noninvasive biomarker of early treatment response in patients with metastatic ovarian carcinoma: A pilot study", "label": "Increased circulating tumor DNA as a noninvasive biomarker of early treatment response in patients with metastatic ovarian carcinoma: A pilot study", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "label": "Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA125 (MUC16)", "label": "CA125 (MUC16)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OSTEOPONTIN (OPN)", "label": "OSTEOPONTIN (OPN)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGF (VEGF-A", "label": "VEGF (VEGF-A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::B", "label": "B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C", "label": "C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::D", "label": "D", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PLGF)", "label": "PLGF)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MESOTHELIN (MSLN)", "label": "MESOTHELIN (MSLN)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MUCIN-1 (MUC1)", "label": "MUCIN-1 (MUC1)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MUCIN-16 (MUC16)", "label": "MUCIN-16 (MUC16)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EPITHELIAL CELL ADHESION MOLECULE (EPCAM)", "label": "EPITHELIAL CELL ADHESION MOLECULE (EPCAM)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ERBB2 (HER2)", "label": "ERBB2 (HER2)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CK8 (KRT8)", "label": "CK8 (KRT8)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KRT18", "label": "KRT18", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CDH1", "label": "CDH1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CDH2", "label": "CDH2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VIMENTIN (VIM)", "label": "VIMENTIN (VIM)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::N-CADHERIN (CDH2)", "label": "N-CADHERIN (CDH2)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::E-CADHERIN (CDH1)", "label": "E-CADHERIN (CDH1)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALDH1A1", "label": "ALDH1A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OCT4", "label": "OCT4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NANOG", "label": "NANOG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TWIST1", "label": "TWIST1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SNAI2", "label": "SNAI2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP7", "label": "MMP7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::WISP1", "label": "WISP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAM8", "label": "ADAM8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLK11", "label": "KLK11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::WFDC2", "label": "WFDC2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOA1", "label": "APOA1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TF", "label": "TF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TTR", "label": "TTR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::\u03922-MICROGLOBULIN (B2M)", "label": "\u03922-MICROGLOBULIN (B2M)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AKT2", "label": "AKT2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGFA", "label": "VEGFA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGFB", "label": "VEGFB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGFC", "label": "VEGFC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PGF", "label": "PGF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SPP1", "label": "SPP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "label": "KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KPNA2", "label": "KPNA2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IMPORTIN BETA 1", "label": "IMPORTIN BETA 1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALP", "label": "ALP", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::14", "label": "14", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis", "label": "Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IDO", "label": "IDO", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Evaluation of Combined Cancer Markers With Lactate Dehydrogenase and Application of Machine Learning Algorithms for Differentiating Benign Disease From Malignant Ovarian Cancer", "label": "Evaluation of Combined Cancer Markers With Lactate Dehydrogenase and Application of Machine Learning Algorithms for Differentiating Benign Disease From Malignant Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LACTATE DEHYDROGENASE", "label": "LACTATE DEHYDROGENASE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HUMAN EPIDIDYMIS PROTEIN 4", "label": "HUMAN EPIDIDYMIS PROTEIN 4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CANCER ANTIGEN 125", "label": "CANCER ANTIGEN 125", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SPECIAL AT-RICH-BINDING PROTEIN 1", "label": "SPECIAL AT-RICH-BINDING PROTEIN 1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::3D8 ANTI-HE4 CONJUGATE", "label": "3D8 ANTI-HE4 CONJUGATE", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "label": "HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GLYCODELIN", "label": "GLYCODELIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "label": "Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DCR3", "label": "DCR3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SPONDIN-2", "label": "SPONDIN-2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "label": "Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MUC-1", "label": "MUC-1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "label": "Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GALECTIN-4", "label": "GALECTIN-4", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "label": "Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ACAT1 PROTEIN", "label": "ACAT1 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KI-67 PROTEIN", "label": "KI-67 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SREBP1", "label": "SREBP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "label": "Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AURKA", "label": "AURKA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BRCA1", "label": "BRCA1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BRD4", "label": "BRD4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CDK2", "label": "CDK2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VRK1", "label": "VRK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GALK1", "label": "GALK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HDAC4", "label": "HDAC4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::STAT1", "label": "STAT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PIK3R1", "label": "PIK3R1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GSK3B", "label": "GSK3B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MYC", "label": "MYC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MDM2", "label": "MDM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HURP", "label": "HURP", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "label": "BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BAIAP2L1 PROTEIN", "label": "BAIAP2L1 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BAIAP2", "label": "BAIAP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IRSP53", "label": "IRSP53", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FGFR3", "label": "FGFR3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IRS1", "label": "IRS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IRS2", "label": "IRS2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SRC", "label": "SRC", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "label": "Microvesicles as Potential Ovarian Cancer Biomarkers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EGFRVIII", "label": "EGFRVIII", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::UPA", "label": "UPA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MT1-MMP", "label": "MT1-MMP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CATHEPSIN B", "label": "CATHEPSIN B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FGF-2", "label": "FGF-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LAMP1", "label": "LAMP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FASL", "label": "FASL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FAS LIGAND", "label": "FAS LIGAND", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TISSUE FACTOR", "label": "TISSUE FACTOR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TISSUE TRANSGLUTAMINASE", "label": "TISSUE TRANSGLUTAMINASE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HAPTOGLOBIN", "label": "HAPTOGLOBIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD40", "label": "CD40", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "label": "Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SOLUBLE EGFR", "label": "SOLUBLE EGFR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGFR-1", "label": "VEGFR-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NEUROPILIN-1", "label": "NEUROPILIN-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ANGIOPOIETIN-1", "label": "ANGIOPOIETIN-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TIE2", "label": "TIE2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TIMP-1", "label": "TIMP-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HLA-G", "label": "HLA-G", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD3", "label": "CD3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD103", "label": "CD103", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ABCG2", "label": "ABCG2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLK", "label": "KLK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLK1", "label": "KLK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLK2", "label": "KLK2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KLK15", "label": "KLK15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD133", "label": "CD133", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CCR2", "label": "CCR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NIVOLUMAB", "label": "NIVOLUMAB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AVELUMAB", "label": "AVELUMAB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IPILIMUMAB", "label": "IPILIMUMAB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HSD17B12", "label": "HSD17B12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGFBI", "label": "TGFBI", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SFRP5", "label": "SFRP5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FZD4", "label": "FZD4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DVL1", "label": "DVL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NFATC3", "label": "NFATC3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ROCK1", "label": "ROCK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LRP5", "label": "LRP5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AXIN1", "label": "AXIN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NKD1", "label": "NKD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ROR1", "label": "ROR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OPCML", "label": "OPCML", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "label": "Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "label": "Biomarkers and Strategies for Early Detection of Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::V-CAM1", "label": "V-CAM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MACROPHAGE MIGRATION INHIBITORY FACTOR", "label": "MACROPHAGE MIGRATION INHIBITORY FACTOR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CHI3L1", "label": "CHI3L1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PEBP4", "label": "PEBP4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AGR2", "label": "AGR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LCAT", "label": "LCAT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PROTEIN Z", "label": "PROTEIN Z", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C-REACTIVE PROTEIN", "label": "C-REACTIVE PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NY-ESO-1", "label": "NY-ESO-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRIM-21", "label": "TRIM-21", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PAX-8", "label": "PAX-8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PTGFR", "label": "PTGFR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PTPRA", "label": "PTPRA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review", "label": "Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "label": "Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IAP", "label": "IAP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HP-A", "label": "HP-A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OVX-1", "label": "OVX-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOA-I", "label": "APOA-I", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRANSFERRIN (TF)", "label": "TRANSFERRIN (TF)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRANSTHYRETIN (TTR)", "label": "TRANSTHYRETIN (TTR)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::H4 (INTER-A-TRYPSIN INHIBITOR HEAVY CHAIN FRAGMENT)", "label": "H4 (INTER-A-TRYPSIN INHIBITOR HEAVY CHAIN FRAGMENT)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GLYCOPROTEINS", "label": "GLYCOPROTEINS", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Ovarian cancer biomarkers as diagnostic  \r\ntriage tests", "label": "Ovarian cancer biomarkers as diagnostic  \r\ntriage tests", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PREALBUMIN", "label": "PREALBUMIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "label": "CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PHOSPHO-AKT", "label": "PHOSPHO-AKT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PHOSPHO-ERK", "label": "PHOSPHO-ERK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PHOSPHO-NF-\u039aB", "label": "PHOSPHO-NF-\u039aB", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "label": "CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CX3CR1", "label": "CX3CR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CX3CL1", "label": "CX3CL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HAVCR2", "label": "HAVCR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CSF1R", "label": "CSF1R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCR2", "label": "CXCR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CCR5", "label": "CCR5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HLA-DMA", "label": "HLA-DMA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HLA-DPA1", "label": "HLA-DPA1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "label": "A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PCNA", "label": "PCNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TUBB3", "label": "TUBB3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOE", "label": "APOE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CLDN3", "label": "CLDN3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FASN", "label": "FASN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LAMP2B", "label": "LAMP2B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FLOTILLIN", "label": "FLOTILLIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ANNEXIN", "label": "ANNEXIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAM15", "label": "ADAM15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CLAUDIN-4", "label": "CLAUDIN-4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LGALS3BP", "label": "LGALS3BP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GELATINOLYTIC ENZYMES", "label": "GELATINOLYTIC ENZYMES", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD171", "label": "CD171", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DNAM-1", "label": "DNAM-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PVR", "label": "PVR", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "label": "CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCR4", "label": "CXCR4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCL12", "label": "CXCL12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SDF-1", "label": "SDF-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SLUG", "label": "SLUG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SOX2", "label": "SOX2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OCT-4", "label": "OCT-4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P-PI3K", "label": "P-PI3K", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P-AKT", "label": "P-AKT", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "label": "Biomarkers in ovarian cancer: To be or not to be", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SPARC", "label": "SPARC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD31", "label": "CD31", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "label": "Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MCM5", "label": "MCM5", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis", "label": "Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CARBOHYDRATE ANTIGEN125", "label": "CARBOHYDRATE ANTIGEN125", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "label": "Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "label": "Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRANSFERRIN RECEPTOR 1 (TFR1)", "label": "TRANSFERRIN RECEPTOR 1 (TFR1)", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "label": "Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "label": "Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SVCAM", "label": "SVCAM", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "label": "ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-2 RECEPTOR ALPHA", "label": "IL-2 RECEPTOR ALPHA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALPHA-1-ANTITRYPSIN", "label": "ALPHA-1-ANTITRYPSIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::YKL-40", "label": "YKL-40", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CELLULAR FIBRONECTIN", "label": "CELLULAR FIBRONECTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA-72-4", "label": "CA-72-4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGF-B", "label": "VEGF-B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CALPROTECTIN", "label": "CALPROTECTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IGFBP-2", "label": "IGFBP-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LOX-1", "label": "LOX-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TNFR2", "label": "TNFR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MPIF-1", "label": "MPIF-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MASPIN", "label": "MASPIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGF-D", "label": "VEGF-D", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KALLIKREIN-7", "label": "KALLIKREIN-7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PILIN-1", "label": "PILIN-1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "label": "Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::14-3-3ETA", "label": "14-3-3ETA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "label": "A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GM130", "label": "GM130", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GRP94", "label": "GRP94", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Confirmation of the utility of the  \r\nCA-125 elimination rate (KELIM) as an \r\nindicator of the chemosensitivity in \r\nadvanced-stage ovarian cancer in a \r\n\u201creal-life setting\u201d", "label": "Confirmation of the utility of the  \r\nCA-125 elimination rate (KELIM) as an \r\nindicator of the chemosensitivity in \r\nadvanced-stage ovarian cancer in a \r\n\u201creal-life setting\u201d", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::DEF6 expression in ovarian carcinoma correlates with poor patient survival", "label": "DEF6 expression in ovarian carcinoma correlates with poor patient survival", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DEF6", "label": "DEF6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IBP", "label": "IBP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BETA-ACTIN", "label": "BETA-ACTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P16", "label": "P16", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ER", "label": "ER", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "label": "Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DESMOGLEIN-2 (DSG2)", "label": "DESMOGLEIN-2 (DSG2)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)", "label": "EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CLAUDIN-7", "label": "CLAUDIN-7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P27", "label": "P27", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::6D8 (DSG2-SPECIFIC ANTIBODY)", "label": "6D8 (DSG2-SPECIFIC ANTIBODY)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RECOMBINANT HUMAN DSG2 PROTEIN", "label": "RECOMBINANT HUMAN DSG2 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::JUNCTION OPENER (JO)", "label": "JUNCTION OPENER (JO)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR (CAR)", "label": "COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR (CAR)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MATRIX METALLOPROTEINASE (MMP)", "label": "MATRIX METALLOPROTEINASE (MMP)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PAK1", "label": "PAK1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "label": "Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CK7", "label": "CK7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CK20", "label": "CK20", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PR", "label": "PR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C-ERBB2", "label": "C-ERBB2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P-GP", "label": "P-GP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OC125", "label": "OC125", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MA1-90039", "label": "MA1-90039", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MA5-15604", "label": "MA5-15604", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MA1-35556", "label": "MA1-35556", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MA5-13304", "label": "MA5-13304", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MA1-410", "label": "MA1-410", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MA5-13675", "label": "MA5-13675", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MA5-13854", "label": "MA5-13854", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum", "label": "Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ACTIN", "label": "ACTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GELSOLIN", "label": "GELSOLIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ACTIN-GELSOLIN COMPLEX", "label": "ACTIN-GELSOLIN COMPLEX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GELSOLIN1-3", "label": "GELSOLIN1-3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ACTIN-RHODAMINE", "label": "ACTIN-RHODAMINE", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients", "label": "Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "label": "Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HCG", "label": "HCG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HCG BETA SUBUNIT", "label": "HCG BETA SUBUNIT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HCG BETA CORE FRAGMENT", "label": "HCG BETA CORE FRAGMENT", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Diagnostic role of urine human epididymis protein 4 in ovarian cancer", "label": "Diagnostic role of urine human epididymis protein 4 in ovarian cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "label": "Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "label": "Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::A1AT", "label": "A1AT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AACT", "label": "AACT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CO9", "label": "CO9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HPT", "label": "HPT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::A2MG", "label": "A2MG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALS", "label": "ALS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IBP3", "label": "IBP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PON1", "label": "PON1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ITIH3", "label": "ITIH3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LG3BP", "label": "LG3BP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FIBA", "label": "FIBA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FIBB", "label": "FIBB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PGRP2", "label": "PGRP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOH", "label": "APOH", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CERU", "label": "CERU", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CO7", "label": "CO7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CO8G", "label": "CO8G", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CO8B", "label": "CO8B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HGF", "label": "HGF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MASP1", "label": "MASP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SEPP1", "label": "SEPP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LUM", "label": "LUM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FBLN1", "label": "FBLN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CHLE", "label": "CHLE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ACTG", "label": "ACTG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IGLL5", "label": "IGLL5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IGHG2", "label": "IGHG2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GELS", "label": "GELS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALDOA", "label": "ALDOA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::THBG", "label": "THBG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HEP2", "label": "HEP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD5L", "label": "CD5L", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FA10", "label": "FA10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KAIN", "label": "KAIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CBPN", "label": "CBPN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AAL", "label": "AAL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CON-A", "label": "CON-A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ECA", "label": "ECA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LPHA", "label": "LPHA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SNA", "label": "SNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::STL", "label": "STL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::WFA", "label": "WFA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "label": "A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ITGAV", "label": "ITGAV", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CEACAM1", "label": "CEACAM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-10RB", "label": "IL-10RB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCL6", "label": "CXCL6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MK", "label": "MK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FR-ALPHA", "label": "FR-ALPHA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGFR-2", "label": "VEGFR-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TNFRSF6B", "label": "TNFRSF6B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CTSV", "label": "CTSV", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SCF", "label": "SCF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TNFRSF4", "label": "TNFRSF4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CDCP1", "label": "CDCP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RSPO3", "label": "RSPO3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TFPI-2", "label": "TFPI-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-15RA", "label": "IL-15RA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-18R1", "label": "IL-18R1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-12B", "label": "IL-12B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-17C", "label": "IL-17C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PVRL4", "label": "PVRL4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP-1", "label": "MMP-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OPG", "label": "OPG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ESM-1", "label": "ESM-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FGF-21", "label": "FGF-21", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::STAMPB", "label": "STAMPB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::METAP2", "label": "METAP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CASP-8", "label": "CASP-8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TNFB", "label": "TNFB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CCL3", "label": "CCL3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CCL4", "label": "CCL4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CCL23", "label": "CCL23", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCL5", "label": "CXCL5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ICOSLG", "label": "ICOSLG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TNFRSF9", "label": "TNFRSF9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LYN", "label": "LYN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LYPD3", "label": "LYPD3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SIRT2", "label": "SIRT2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EPHA2", "label": "EPHA2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::4E-BP1", "label": "4E-BP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FADD", "label": "FADD", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DNER", "label": "DNER", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ABL1", "label": "ABL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TXLNA", "label": "TXLNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAM-TS15", "label": "ADAM-TS15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FURIN", "label": "FURIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SYND1", "label": "SYND1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::S100A4", "label": "S100A4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD27", "label": "CD27", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LAPTGF-BETA-1", "label": "LAPTGF-BETA-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IC0SLG", "label": "IC0SLG", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "label": "Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DOLICHYL-PHOSPHATE BETA-GLUCOSYLTRANSFERASE", "label": "DOLICHYL-PHOSPHATE BETA-GLUCOSYLTRANSFERASE", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "label": "Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::STREPTAVIDIN", "label": "STREPTAVIDIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::METHYL-CPG BINDING PROTEIN", "label": "METHYL-CPG BINDING PROTEIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "label": "Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Evaluation of HE4, CA-125, Risk of Ovarian \r\nMalignancy Algorithm (ROMA) and Risk of \r\nMalignancy Index (RMI) in the Preoperative \r\nAssessment of Patients with Adnexal Mass", "label": "Evaluation of HE4, CA-125, Risk of Ovarian \r\nMalignancy Algorithm (ROMA) and Risk of \r\nMalignancy Index (RMI) in the Preoperative \r\nAssessment of Patients with Adnexal Mass", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "label": "Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HIF", "label": "HIF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TAQ POLYMERASE", "label": "TAQ POLYMERASE", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "label": "Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SV40 LARGE T ANTIGEN", "label": "SV40 LARGE T ANTIGEN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies", "label": "Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Expression and clinical significance of survivin in ovarian cancer: A meta-analysis", "label": "Expression and clinical significance of survivin in ovarian cancer: A meta-analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SURVIVIN", "label": "SURVIVIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "label": "Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NOTCH-1", "label": "NOTCH-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OCT3", "label": "OCT3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::4A", "label": "4A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NESTIN", "label": "NESTIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SSEA1", "label": "SSEA1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SSEA4", "label": "SSEA4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BER-EP4", "label": "BER-EP4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MOC31", "label": "MOC31", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "label": "A multiplex platform for the identification of ovarian cancer biomarkers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HK11", "label": "HK11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TNFSF14", "label": "TNFSF14", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PRSS8", "label": "PRSS8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FUR", "label": "FUR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CXCL10", "label": "CXCL10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CSF1", "label": "CSF1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NTRK3", "label": "NTRK3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ERBB4", "label": "ERBB4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VEGFR2", "label": "VEGFR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::UPAR", "label": "UPAR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LAP.TGF-\u03921", "label": "LAP.TGF-\u03921", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PARK7", "label": "PARK7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SELE", "label": "SELE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PDGF-B", "label": "PDGF-B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GDF-15", "label": "GDF-15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD40L", "label": "CD40L", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD69", "label": "CD69", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CDH3", "label": "CDH3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGF-\u0391", "label": "TGF-\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TNFR1", "label": "TNFR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CRP", "label": "CRP", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "label": "Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MET", "label": "MET", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKR1", "label": "PKR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CAV1", "label": "CAV1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APAF1", "label": "APAF1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRAIL", "label": "TRAIL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MHC CLASS I", "label": "MHC CLASS I", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::B2M", "label": "B2M", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NKG2D", "label": "NKG2D", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MICA", "label": "MICA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MICB", "label": "MICB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ULBP1", "label": "ULBP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ULBP2", "label": "ULBP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ULBP3", "label": "ULBP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TIM-1", "label": "TIM-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SIGLEC-10", "label": "SIGLEC-10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HSP72", "label": "HSP72", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HSP105", "label": "HSP105", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P-GLYCOPROTEIN", "label": "P-GLYCOPROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ACTN4", "label": "ACTN4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FOXP1", "label": "FOXP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CEBPG", "label": "CEBPG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FMNL3", "label": "FMNL3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RFXAP", "label": "RFXAP", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "label": "GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NLRP3", "label": "NLRP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FCGR", "label": "FCGR", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect", "label": "HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SOLUBLE MESOTHELIN-RELATED PROTEINS", "label": "SOLUBLE MESOTHELIN-RELATED PROTEINS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HUMAN BRADYKININ-RELEASING ENZYME FAMILY", "label": "HUMAN BRADYKININ-RELEASING ENZYME FAMILY", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "label": "Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HELQ", "label": "HELQ", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RPA70", "label": "RPA70", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RPA32", "label": "RPA32", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::XPC", "label": "XPC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::XPA", "label": "XPA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ERCC1", "label": "ERCC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ATM", "label": "ATM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C-ABL", "label": "C-ABL", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "label": "High BMP7 expression is associated with poor prognosis in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BMP7 PROTEIN", "label": "BMP7 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NOGGIN", "label": "NOGGIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CALPAIN-1", "label": "CALPAIN-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CALPAIN-2", "label": "CALPAIN-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CALPAIN-4", "label": "CALPAIN-4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CALPASTATIN", "label": "CALPASTATIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma", "label": "High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "label": "Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CALCINEURIN", "label": "CALCINEURIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CALCINEURIN A CATALYTIC SUBUNIT", "label": "CALCINEURIN A CATALYTIC SUBUNIT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CALCINEURIN B REGULATORY SUBUNIT", "label": "CALCINEURIN B REGULATORY SUBUNIT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NFAT", "label": "NFAT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DAXX", "label": "DAXX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RB", "label": "RB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C-MYC", "label": "C-MYC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CHP2", "label": "CHP2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "label": "Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKP1 PROTEIN", "label": "PKP1 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKP2 PROTEIN", "label": "PKP2 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKP3 PROTEIN", "label": "PKP3 PROTEIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "label": "Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CYP2E1", "label": "CYP2E1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::COX-2", "label": "COX-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::5-LOX", "label": "5-LOX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SRC FAMILY KINASES", "label": "SRC FAMILY KINASES", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::UROKINASE-TYPE PLASMINOGEN ACTIVATOR", "label": "UROKINASE-TYPE PLASMINOGEN ACTIVATOR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CYCLIN D1", "label": "CYCLIN D1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::YAP", "label": "YAP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DGK\u0391", "label": "DGK\u0391", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "label": "A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL-1RA", "label": "IL-1RA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DKK-1", "label": "DKK-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::E-CAD", "label": "E-CAD", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LCN2", "label": "LCN2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "label": "Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MAPK13", "label": "MAPK13", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::OGG1", "label": "OGG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PLA2R1", "label": "PLA2R1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SCGB1A1", "label": "SCGB1A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SIGMAR1", "label": "SIGMAR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SLC7A11", "label": "SLC7A11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRPM2", "label": "TRPM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DUOX1", "label": "DUOX1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FOXO1", "label": "FOXO1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GPR37", "label": "GPR37", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL18BP", "label": "IL18BP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ARL6IP5", "label": "ARL6IP5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD38", "label": "CD38", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MELK", "label": "MELK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NAPRT", "label": "NAPRT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NDUFB4", "label": "NDUFB4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SIRPA", "label": "SIRPA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TTN", "label": "TTN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DNAH3", "label": "DNAH3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DNAH5", "label": "DNAH5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DNAH9", "label": "DNAH9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DNAH10", "label": "DNAH10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DNAH17", "label": "DNAH17", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LRP2", "label": "LRP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LRP1B", "label": "LRP1B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MGA", "label": "MGA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VCAN", "label": "VCAN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ZFHX3", "label": "ZFHX3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PCLO", "label": "PCLO", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LCT", "label": "LCT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ARID1B", "label": "ARID1B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AIM1", "label": "AIM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PD-L2", "label": "PD-L2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::B7-H3", "label": "B7-H3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD58", "label": "CD58", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD70", "label": "CD70", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD270", "label": "CD270", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TIGIT", "label": "TIGIT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LAG3", "label": "LAG3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TIM-3", "label": "TIM-3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ICOS", "label": "ICOS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IDO1", "label": "IDO1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD276", "label": "CD276", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HVEM", "label": "HVEM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PDCD1", "label": "PDCD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PDCD1LG2", "label": "PDCD1LG2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD274", "label": "CD274", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "label": "Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::COL3A1", "label": "COL3A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GPR158", "label": "GPR158", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PITHD1", "label": "PITHD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::COL11A1", "label": "COL11A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MTUS1", "label": "MTUS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EHD3", "label": "EHD3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FRMPD2", "label": "FRMPD2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GABRP", "label": "GABRP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GID4", "label": "GID4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GRM5", "label": "GRM5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IGHG1", "label": "IGHG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::JCHAIN", "label": "JCHAIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KIF26B", "label": "KIF26B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MAP7D2", "label": "MAP7D2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MTRNR2L1", "label": "MTRNR2L1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MUC15", "label": "MUC15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RTKN2", "label": "RTKN2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SLC9A4", "label": "SLC9A4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SMYD2", "label": "SMYD2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRIM71", "label": "TRIM71", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRIO", "label": "TRIO", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TTK", "label": "TTK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VNN1", "label": "VNN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ARHGAP21", "label": "ARHGAP21", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ARMC3", "label": "ARMC3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::C7", "label": "C7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CDH18", "label": "CDH18", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CES3", "label": "CES3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "label": "Improved early detection of ovarian cancer using longitudinal multimarker models", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LRG1", "label": "LRG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FSTL1", "label": "FSTL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PAEP", "label": "PAEP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HP", "label": "HP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ORM1", "label": "ORM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ORM2", "label": "ORM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SAA1", "label": "SAA1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "label": "Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IGF1R", "label": "IGF1R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PDGF", "label": "PDGF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PDGFRB", "label": "PDGFRB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FGFR1", "label": "FGFR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL8", "label": "IL8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MCL1", "label": "MCL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CDKN1A", "label": "CDKN1A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BIK", "label": "BIK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CLDN4", "label": "CLDN4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CLDN5", "label": "CLDN5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::POSTN", "label": "POSTN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LPAR2", "label": "LPAR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LPAR3", "label": "LPAR3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PLAU", "label": "PLAU", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BCLXL", "label": "BCLXL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BCLW", "label": "BCLW", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HDAC1", "label": "HDAC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SNAI1", "label": "SNAI1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FR\u0391", "label": "FR\u0391", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "label": "Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KALLIKREIN-5", "label": "KALLIKREIN-5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KALLIKREIN-11", "label": "KALLIKREIN-11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KALLIKREIN-8", "label": "KALLIKREIN-8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KALLIKREIN-4", "label": "KALLIKREIN-4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KALLIKREIN-6", "label": "KALLIKREIN-6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KALLIKREIN-15", "label": "KALLIKREIN-15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KALLIKREIN-3", "label": "KALLIKREIN-3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial", "label": "Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "label": "Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EUKARYOTIC TRANSLATION INITIATION FACTOR 2B SUBUNIT 5", "label": "EUKARYOTIC TRANSLATION INITIATION FACTOR 2B SUBUNIT 5", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "label": "Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MEGAKARYOCYTE POTENTIATING FACTOR", "label": "MEGAKARYOCYTE POTENTIATING FACTOR", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Metabonomics study of the serum from ovarian cancer patients", "label": "Metabonomics study of the serum from ovarian cancer patients", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::APOA4 PROTEIN", "label": "APOA4 PROTEIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "label": "MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::\u0392-TUBULIN III", "label": "\u0392-TUBULIN III", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MMP-3", "label": "MMP-3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HMGA2", "label": "HMGA2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ZEB2", "label": "ZEB2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PDCD4", "label": "PDCD4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::P38\u0391", "label": "P38\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SMAD2", "label": "SMAD2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SMAD3", "label": "SMAD3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SMAD7", "label": "SMAD7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NODAL", "label": "NODAL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ALK7", "label": "ALK7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IGF2", "label": "IGF2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PDGFRA", "label": "PDGFRA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DICER1", "label": "DICER1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TRBP", "label": "TRBP", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "label": "ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAM12", "label": "ADAM12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAM12-L", "label": "ADAM12-L", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAM12-S", "label": "ADAM12-S", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SV40 LARGE T-ANTIGEN", "label": "SV40 LARGE T-ANTIGEN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ADAM12 PROTEIN", "label": "ADAM12 PROTEIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "label": "MicroRNAs as Potential Biomarkers in Gynecological Cancers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::EXPORTIN-5", "label": "EXPORTIN-5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGFBR1", "label": "TGFBR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MAPK1", "label": "MAPK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TP63", "label": "TP63", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HIF-3\u0391", "label": "HIF-3\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FHIT", "label": "FHIT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ZBTB4", "label": "ZBTB4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CDC42", "label": "CDC42", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CCND1", "label": "CCND1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MYB", "label": "MYB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SOX4", "label": "SOX4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KIF4A", "label": "KIF4A", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "label": "Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MCL-1", "label": "MCL-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::\u0391-TUBULIN", "label": "\u0391-TUBULIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "label": "Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::INTEGRIN BETA-5", "label": "INTEGRIN BETA-5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ESTROGEN RECEPTOR-\u0391 (ER-\u0391)", "label": "ESTROGEN RECEPTOR-\u0391 (ER-\u0391)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::INSULIN", "label": "INSULIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HE4 ANTIBODY", "label": "HE4 ANTIBODY", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::INTEGRIN \u03925 MONOCLONAL ANTIBODY", "label": "INTEGRIN \u03925 MONOCLONAL ANTIBODY", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of ICAM-1 Predicts Poor Survival in\r\n High-Grade Serous Ovarian Carcinoma: A Study Based on\r\n TCGAandGEODatabases and Tissue Microarray", "label": "Overexpression of ICAM-1 Predicts Poor Survival in\r\n High-Grade Serous Ovarian Carcinoma: A Study Based on\r\n TCGAandGEODatabases and Tissue Microarray", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD54", "label": "CD54", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "label": "Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "label": "Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::REDD1", "label": "REDD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::MTORC1", "label": "MTORC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TSC1", "label": "TSC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TSC2", "label": "TSC2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HIF1", "label": "HIF1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "label": "PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD8 PROTEIN", "label": "PSMD8 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD14 PROTEIN", "label": "PSMD14 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD1 PROTEIN", "label": "PSMD1 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD2 PROTEIN", "label": "PSMD2 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD3 PROTEIN", "label": "PSMD3 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD4 PROTEIN", "label": "PSMD4 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD5 PROTEIN", "label": "PSMD5 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD6 PROTEIN", "label": "PSMD6 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD7 PROTEIN", "label": "PSMD7 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD9 PROTEIN", "label": "PSMD9 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD10 PROTEIN", "label": "PSMD10 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD11 PROTEIN", "label": "PSMD11 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD12 PROTEIN", "label": "PSMD12 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMD13 PROTEIN", "label": "PSMD13 PROTEIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMC1", "label": "PSMC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMC2", "label": "PSMC2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMC3", "label": "PSMC3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMC4", "label": "PSMC4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMC5", "label": "PSMC5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PSMC6", "label": "PSMC6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GANKYRIN", "label": "GANKYRIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GRP78", "label": "GRP78", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKM2", "label": "PKM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::E2F1", "label": "E2F1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RB1", "label": "RB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL10RB", "label": "IL10RB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD48", "label": "CD48", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AQN1", "label": "AQN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ATG7", "label": "ATG7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ACVR1", "label": "ACVR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BMP6", "label": "BMP6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKM", "label": "PKM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HLA-A", "label": "HLA-A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::HLA-C", "label": "HLA-C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TAP1", "label": "TAP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NFE2L2", "label": "NFE2L2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "label": "Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKC\u0393", "label": "PKC\u0393", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKC\u0391", "label": "PKC\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PKC\u0395", "label": "PKC\u0395", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CONNEXIN 43", "label": "CONNEXIN 43", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CX43", "label": "CX43", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IP3R", "label": "IP3R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CX26", "label": "CX26", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CX32", "label": "CX32", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FGFR", "label": "FGFR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::A24S", "label": "A24S", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::K359R", "label": "K359R", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "label": "Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PEROXIREDOXIN-1 (PRDX-1)", "label": "PEROXIREDOXIN-1 (PRDX-1)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ESTROGEN RECEPTOR (ER)", "label": "ESTROGEN RECEPTOR (ER)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ESTROGEN RECEPTOR ALPHA (ER\u0391)", "label": "ESTROGEN RECEPTOR ALPHA (ER\u0391)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ANDROGEN RECEPTOR (AR)", "label": "ANDROGEN RECEPTOR (AR)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)", "label": "VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ASK1", "label": "ASK1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "label": "Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DNA POLYMERASE", "label": "DNA POLYMERASE", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "label": "APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::IL10", "label": "IL10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ARG1", "label": "ARG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::AIF1", "label": "AIF1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LILRB4", "label": "LILRB4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TYROBP", "label": "TYROBP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::FCER1G", "label": "FCER1G", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LST1", "label": "LST1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GMFG", "label": "GMFG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD80", "label": "CD80", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::KEAP1", "label": "KEAP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NRF2", "label": "NRF2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ABI3", "label": "ABI3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "label": "Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PLASMA GELSOLIN (PGSN)", "label": "PLASMA GELSOLIN (PGSN)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::GELSOLIN (GSN)", "label": "GELSOLIN (GSN)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SEV-PGSN", "label": "SEV-PGSN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CALNEXIN", "label": "CALNEXIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DNMT1", "label": "DNMT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::DNGR-1", "label": "DNGR-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CD4", "label": "CD4", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "label": "Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic Significance of CA125 Dynamic \r\nChange for Progression Free Survival in Patients \r\nwith Epithelial Ovarian Carcinoma", "label": "Prognostic Significance of CA125 Dynamic \r\nChange for Progression Free Survival in Patients \r\nwith Epithelial Ovarian Carcinoma", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "label": "Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGF-\u03922", "label": "TGF-\u03922", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGF-\u03923", "label": "TGF-\u03923", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGF-\u03924", "label": "TGF-\u03924", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::SMAD", "label": "SMAD", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::RAS", "label": "RAS", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "label": "Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "label": "Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::BECLIN1", "label": "BECLIN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::VPS34", "label": "VPS34", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "label": "Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PRC2", "label": "PRC2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LSD1", "label": "LSD1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "label": "Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::ICAM1", "label": "ICAM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::PHOSPHO-EGFR TYR1068", "label": "PHOSPHO-EGFR TYR1068", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::COL6A1", "label": "COL6A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LAMB1", "label": "LAMB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::TGFB1", "label": "TGFB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::NOX ENZYMES", "label": "NOX ENZYMES", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "label": "Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::\u0392-TUBULIN", "label": "\u0392-TUBULIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::LPL", "label": "LPL", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Protocol for identifying metabolite biomarkers in patient uterine fluid for early ovarian cancer detection", "label": "Protocol for identifying metabolite biomarkers in patient uterine fluid for early ovarian cancer detection", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "PROTEINS::CA125 (CANCER ANTIGEN 125)", "label": "CA125 (CANCER ANTIGEN 125)", "shape": "ellipse"}]);
                  edges = new vis.DataSet([{"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::CARCINOEMBRYONIC ANTIGEN (CEA)"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::CANCER ANTIGEN 125 (CA125)"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::CA125-II"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::HE4 (HUMAN EPIDIDYMIS PROTEIN 4)"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::TRANSFERRIN"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::BETA-2-MICROGLOBULIN"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::APOLIPOPROTEIN A-1"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::TRANSTHYRETIN"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::FOLLICLE-STIMULATING HORMONE"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::LACTATE DEHYDROGENASE (LDH)"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::BETA-HCG"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::INHIBIN B"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "PROTEINS::ALPHA-FETOPROTEIN"}, {"from": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "to": "PROTEINS::OSTEOPONTIN"}, {"from": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "to": "PROTEINS::OPN"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "PROTEINS::AHRR"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "PROTEINS::PPP1R3C"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "PROTEINS::AHR"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "PROTEINS::VEGFD"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "PROTEINS::CYTOCHROME P450"}, {"from": "ARTICLE::RAD51 as a Biomarker for Homologous Recombination Deficiency in High\u2010Grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 test", "to": "PROTEINS::RAD51"}, {"from": "ARTICLE::RAD51 as a Biomarker for Homologous Recombination Deficiency in High\u2010Grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 test", "to": "PROTEINS::\u0393H2AX"}, {"from": "ARTICLE::RAD51 as a Biomarker for Homologous Recombination Deficiency in High\u2010Grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 test", "to": "PROTEINS::GEMININ"}, {"from": "ARTICLE::nan", "to": "PROTEINS::NF-\u039aB"}, {"from": "ARTICLE::nan", "to": "PROTEINS::VEGF-A"}, {"from": "ARTICLE::nan", "to": "PROTEINS::TGF-\u03921"}, {"from": "ARTICLE::nan", "to": "PROTEINS::PKC"}, {"from": "ARTICLE::nan", "to": "PROTEINS::BETA-CATENIN"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "PROTEINS::KI-67"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "PROTEINS::AURKB"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "PROTEINS::P53"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::BECLIN-1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::LC3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::BCL-2"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::BCL-XL"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::BAX"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::BAD"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::CASPASE-3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::CASPASE-8"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::CASPASE-9"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::AMPK"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::PKC\u0392"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::MTOR"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::ERBB2"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::ERBB3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::HSP90"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::VEGFR"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::PDGFR"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::KDR"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::IL6R"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::GP130"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::RIPK3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::MLKL"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::MUC16"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::MMP3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::RAF-1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::P62"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::LKB1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::SIRT3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::ALDH"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::GSK3\u0392"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::ERK"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::P38 MAPK"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::NF-\u039aB"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::JAK1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::JAK2"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "PROTEINS::STAT3"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::EGF"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::ERK"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::MAPK"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::PI3K"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::MTOR"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::HIF1\u0391"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::HDAC3"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::JAK"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::STAT3"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::PD-L1"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::PD-1"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::IL-8"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::IL-1\u0391"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::ANXA2"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::CD147"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::MMP-2"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::MMP-9"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::N-CADHERIN"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::SNAIL"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::CASPASE-3"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::CLEAVED CASPASE-3"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::OPN"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "PROTEINS::DUSP6"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::EGR1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::NF-KB"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::BIM"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::PD-1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::PD-L1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::CTLA-4"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::MHC-I"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::OX40L"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::OX40"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::4-1BBL"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::4-1BB"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::DR4"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::CASPASE-8"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::TGF-\u03921"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::VEGF-A"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::VEGFR1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::TROP-2"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::MAGE-A3"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::MAGE-A6"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::SPD-1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::SPD-L1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::IFN-\u0393"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::LEPTIN"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::FIBRINOGEN"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::LDH"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::ARGONAUTE2"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::CD81"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::HDACS"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::SIRT1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "PROTEINS::PARP1"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::OPN"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::MSLN"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::FOLR1"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::CA72.4"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::CD117"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::ALDH"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::HARS"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::RO52"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::CDR2"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::4H4"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::5H6"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::KI67"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "PROTEINS::MUC16"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::PARP"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::MUC16"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::AGO1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::AGO2"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::AGO3"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::AGO4"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::PIWIL1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::PIWIL2"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::PIWIL3"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::PIWIL4"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::YAP1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::SMAD4"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::MTA3"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::MMP3"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::MMP9"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::VIMENTIN"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::SNAIL"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::IASPP"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::MEK1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::ERK1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::JNK1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::TGF\u03921"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::BAX"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::BAK"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::CASPASE-3"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::CASPASE-9"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::SRPK1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::MMP14"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::NF-\u039aB"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::BMI1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::BCL2"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::TIMP1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "PROTEINS::ZEB1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::PTEN"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::VIM"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::ZO-1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::BCL10"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::BCL2L1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::CXCL1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::CXCL8"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::ER\u0391"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::S1PR1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::HK2"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::TAK1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::MAP3K7"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::HIF1A"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::EPAS1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::TNF"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::IRAK1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::TRAF6"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::PIK3CA"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::PIK3CB"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::AKT1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::ABCB1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::GSTP1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::NAV3"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::ITGA5"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::PCDH9"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::RUNX2"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::CHD4"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::HNRNPC"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::NFIX"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::DICER"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::DGCR8"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::AGO2"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::XPO5"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::RAN"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::TARBP2"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::PRKRA"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::ZEB1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::KLF6"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::KLF12"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::SP1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::FBXL10"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "PROTEINS::XIAP"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "PROTEINS::HER2"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "PROTEINS::MUC1"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "PROTEINS::WT1"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "PROTEINS::PAX8"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas", "to": "PROTEINS::BRCA1 PROTEIN"}, {"from": "ARTICLE::Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas", "to": "PROTEINS::BRCA2 PROTEIN"}, {"from": "ARTICLE::Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas", "to": "PROTEINS::PARP"}, {"from": "ARTICLE::SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "to": "PROTEINS::SLC11A2 PROTEIN"}, {"from": "ARTICLE::SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "to": "PROTEINS::\u0392-ACTIN"}, {"from": "ARTICLE::SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "to": "PROTEINS::ANNEXIN V"}, {"from": "ARTICLE::SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "to": "PROTEINS::PARP"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::SPON1"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::F-SPONDIN"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::AMYLOID-\u0392 PRECURSOR PROTEIN (APP)"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::ALPHA-SMOOTH MUSCLE ACTIN (\u0391SMA)"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::CYTOKERATIN"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::ADAMTS1"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::ADAMTS5"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::ADAMTS13"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "PROTEINS::ADAMTS-LIKE PROTEIN"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::SUGT1"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::HSP90"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::SCRIBBLES"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::PAX3-FOXO1"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::EWS-FLI1"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::SCF-\u0392-TRCP"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::TNF"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::IL6"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::STAT3"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::JAK"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "PROTEINS::MTOR"}, {"from": "ARTICLE::Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "to": "PROTEINS::HEPCIDIN"}, {"from": "ARTICLE::Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "to": "PROTEINS::FERROPORTIN"}, {"from": "ARTICLE::Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "to": "PROTEINS::MAGP-2"}, {"from": "ARTICLE::Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "to": "PROTEINS::CA19-9"}, {"from": "ARTICLE::Serum CA125, CA199 and CEA combined detection \r\nfor epithelial ovarian cancer diagnosis: A meta\r\nanalysis", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Serum CA125, CA199 and CEA combined detection \r\nfor epithelial ovarian cancer diagnosis: A meta\r\nanalysis", "to": "PROTEINS::MUC16"}, {"from": "ARTICLE::Serum CA125, CA199 and CEA combined detection \r\nfor epithelial ovarian cancer diagnosis: A meta\r\nanalysis", "to": "PROTEINS::CEA"}, {"from": "ARTICLE::Serum CA125, CA199 and CEA combined detection \r\nfor epithelial ovarian cancer diagnosis: A meta\r\nanalysis", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::EGF"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-7"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-8"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-10"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::G-CSF"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::GM-CSF"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::TNF-\u0391"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IFN-\u0393"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-1\u0391"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-5"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-12P70"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-13"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-15"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-17"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::MCP-1"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IP-10"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::EOTAXIN"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::MIP-1\u0391"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-4"}, {"from": "ARTICLE::Serum Cytokine Profiling as a Diagnostic and Prognostic Tool\r\n in Ovarian Cancer: A Potential Role for Interleukin 7", "to": "PROTEINS::IL-2"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::LRP1"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::MMP2"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::MMP9"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::ERK"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::P-ERK"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::GAPDH"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::CD9"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::CD63"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::TSG101"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::FN1"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::APOA4"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::VWF"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::APOM"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::C1R"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::APOC1"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::SPP2"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::APOD"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "PROTEINS::FCN3"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "PROTEINS::CFL1"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "PROTEINS::EZR"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "PROTEINS::CYPA"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "PROTEINS::PFN1"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "PROTEINS::NAPSA"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "PROTEINS::CA242"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "PROTEINS::AFP"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "PROTEINS::\u0392-HCG"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "PROTEINS::CEA"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "PROTEINS::CA199"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "PROTEINS::NSE"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "PROTEINS::FERRITIN"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "PROTEINS::CA153"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "PROTEINS::HGH"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "PROTEINS::HIF-1\u0391"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "PROTEINS::CK8"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "PROTEINS::CK18"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "PROTEINS::CK19"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "PROTEINS::CD45"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Shortcomings in the evaluation of biomarkers \r\nin ovarian cancer: a systematic review", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Shortcomings in the evaluation of biomarkers \r\nin ovarian cancer: a systematic review", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Shortcomings in the evaluation of biomarkers \r\nin ovarian cancer: a systematic review", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::CancerAntigen125LevelsatTimeofOvarianCancerDiagnosis\r\n byRaceandEthnicity", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::CancerAntigen125LevelsatTimeofOvarianCancerDiagnosis\r\n byRaceandEthnicity", "to": "PROTEINS::MUC-16"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::OSTEOPONTIN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::IL-8"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::APOLIPOPROTEIN A1"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::TRANSTHYRETIN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::TRANSFERRIN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::BETA-2-MICROGLOBULIN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::MMP-7"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::PROSTASIN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::KLK6"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::KLK7"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::KLK9"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::MDK"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::PROS1"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::SLPI"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::TIMP1"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::IGFBP2"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::IGFBP3"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::GRN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::RARRES2"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::CD14"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::CA72-4"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::CA15-3"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::MUC1"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::B7-H4"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::CTLA4"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::PD-1"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::CYTOKERATINS"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::N-CADHERIN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::VIMENTIN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::ESTROGEN RECEPTOR"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::PROGESTERONE RECEPTOR"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "PROTEINS::HER2"}, {"from": "ARTICLE::The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "to": "PROTEINS::CEA"}, {"from": "ARTICLE::The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "to": "PROTEINS::MUC16"}, {"from": "ARTICLE::The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "to": "PROTEINS::PI3K"}, {"from": "ARTICLE::The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "to": "PROTEINS::KALLIKREINS"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::IL6"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::MMPS"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::TNF-\u0391"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::IL6R"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::MAPK"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::ERK"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::P38"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::JNK"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::NF-KB"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::AP-1"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::C-JUN"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::FOS"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::STAT3"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::CD16"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::FC\u0393RIII"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "PROTEINS::E4"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "PROTEINS::TP53"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "PROTEINS::CTIP"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "PROTEINS::MRE11"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "PROTEINS::RAD50"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "PROTEINS::NBS1"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "PROTEINS::H2AX"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "PROTEINS::RPA"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "PROTEINS::RAD52"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::IL-10"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::IL-4"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::IL-13"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::LIF"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::TGF-\u0392"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::TNF-\u0391"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::IFN-\u0393"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::IL-12"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::CCL18"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::CCL22"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::CCL20"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::VEGF-C"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::MMP-9"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::EGF"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::ICAM-1"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::CD163"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::CD206"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::CD68"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::CD86"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::PD-1"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::PD-L1"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::B7-H4"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::STAT3"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::STAT6"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::PI3K"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::IRF4"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::PPAR-\u0393"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::CSF-1"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::CSF-1R"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::NF-\u039aB"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::SOCS3"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "PROTEINS::IGF-1"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::ALIX"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::TSG101"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CD63"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CD37"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CD53"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CD81"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CD82"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CD9"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::HSP84"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::90"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::HSC70"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::MHC I"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::MHC II"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::PHOSPHATE ISOMERASE"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::PEROXIREDOXIN"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::ALDEHYDE REDUCTASE"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::FATTY ACID SYNTHASE"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::ANNEXIN A3"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::ANNEXIN A2"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CEA"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::HER2"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::MMP2"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::MMP9"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CD44V6"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CD105"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::L1CAM"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::ADAM10"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::EMMPRIN"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CD24"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::RAB27A"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::VEGFR1"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::FLOTILLIN2"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::HSP70"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::WNT"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::TGF\u0392"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::TNF\u0391"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::IL-8"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::ILK1"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::\u0392-CATENIN"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::HEPATOMA-DERIVED GROWTH FACTOR"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CASEIN KINASE II"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::INTEGRIN 3"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::CAVEOLIN-1"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::HNRNPA2B1"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::RISC"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::DROSHA"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::DICER"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "PROTEINS::RNA POLYMERASE II"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::PD-1"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::PD-L1"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::CTLA-4"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::GZMB"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::IFN-\u0393"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::CD8"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::KI-67"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::TGF-\u0392"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::CXCR5"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::VEGFR3"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::CXCL9"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::CXCL11"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "PROTEINS::CXCL13"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::APOLIPOPROTEIN A1"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::TRANSFERRIN"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::TRANSTHYRETIN"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::BETA-2-MACROGLOBULIN"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::APOLIPOPROTEIN A4"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::APOLIPOPROTEIN E"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::NITRIC OXIDE SYNTHASE"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::NF-\u039aB"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::CYCLOOXYGENASE-2"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::CD24"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "to": "PROTEINS::C5A"}, {"from": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "to": "PROTEINS::C5AR1"}, {"from": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "to": "PROTEINS::C5AR"}, {"from": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "to": "PROTEINS::BETA-CATENIN"}, {"from": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "to": "PROTEINS::ERK1"}, {"from": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "to": "PROTEINS::2"}, {"from": "ARTICLE::The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis", "to": "PROTEINS::BEVACIZUMAB"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::GALECTIN-1"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::GALECTIN-3"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::GALECTIN-7"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::GALECTIN-8"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::GALECTIN-9"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::NF-\u039aB (P65)"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::MMP-9"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::MMP-2"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::BCL-2"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::P21"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::C-JUN"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::HRAS"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::RAF-1"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::MEK"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::ERK"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::ERK1"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::2"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::PI3K"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::CD45"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::CD71"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::CD95"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::FAS"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::BFGF"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::MYD88"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::CAV-1"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::TLR4"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::GPIB"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::COL4A1"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::CD166"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::NOTCH1"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::KRAS"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::STAT3"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::P-STAT3"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "PROTEINS::JNK"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::OSTEOPONTIN"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::LEPTIN"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::PROLACTIN"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::IGF-II"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::MIF"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::IL-8"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::G-CSF"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::EOTAXIN-1"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::CVCAM"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::IL-2R ALPHA"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::M-CSF"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::APOLIPOPROTEIN A1"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::TRANSTHYRETIN"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::INTER-ALPHA-TRYPSIN INHIBITOR HEAVY CHAIN H4"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::B2-MICROGLOBULIN"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::SMRP"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::CA72-4"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::ALDH1"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "PROTEINS::CA19-9"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "PROTEINS::TAAR1"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "PROTEINS::ER-\u0391"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "PROTEINS::ER-\u0392"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "PROTEINS::PR-A"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "PROTEINS::PR-B"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "PROTEINS::GPER"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "PROTEINS::GPR30"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "PROTEINS::MUC1"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "PROTEINS::GLYCODELINA"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "PROTEINS::ODC"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::MSN"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::KRT19"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::KRT7"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::JUNB"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::COL5A2"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::COL1A2"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::BMP5"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::F10"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::BMP4"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::MMP1"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::KLK4"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::KLK5"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::KLK6"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::KLK7"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::EZR"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::RDX"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::TGF\u0392-1"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::ALK1"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::BMP9"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::BMP10"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::CYFRA 21-1"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "PROTEINS::GAPDH"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "PROTEINS::ZNF76"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "PROTEINS::P53"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "PROTEINS::TATA-BINDING PROTEIN"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "PROTEINS::STAF"}, {"from": "ARTICLE::Increased circulating tumor DNA as a noninvasive biomarker of early treatment response in patients with metastatic ovarian carcinoma: A pilot study", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Increased circulating tumor DNA as a noninvasive biomarker of early treatment response in patients with metastatic ovarian carcinoma: A pilot study", "to": "PROTEINS::PARP"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::CA125 (MUC16)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::OSTEOPONTIN (OPN)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::VEGF (VEGF-A"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::B"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::C"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::D"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::PLGF)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::MESOTHELIN (MSLN)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::MUCIN-1 (MUC1)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::MUCIN-16 (MUC16)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::EPITHELIAL CELL ADHESION MOLECULE (EPCAM)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::ERBB2 (HER2)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::CK8 (KRT8)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::KRT7"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::KRT18"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::KRT19"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::CDH1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::CDH2"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::VIMENTIN (VIM)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::N-CADHERIN (CDH2)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::E-CADHERIN (CDH1)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::ALDH1A1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::OCT4"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::NANOG"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::TWIST1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::ZEB1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::SNAI2"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::MMP7"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::MDK"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::CXCL13"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::WISP1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::ADAM8"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::KLK11"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::FOLR1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::MSLN"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::WFDC2"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::APOA1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::TF"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::TTR"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::\u03922-MICROGLOBULIN (B2M)"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::PIK3CA"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::AKT2"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::VEGFA"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::VEGFB"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::VEGFC"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::VEGFD"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::PGF"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "PROTEINS::SPP1"}, {"from": "ARTICLE::KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "to": "PROTEINS::KPNA2"}, {"from": "ARTICLE::KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "to": "PROTEINS::IMPORTIN BETA 1"}, {"from": "ARTICLE::KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "to": "PROTEINS::ALP"}, {"from": "ARTICLE::KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "to": "PROTEINS::LDH"}, {"from": "ARTICLE::14", "to": "PROTEINS::APOLIPOPROTEIN A1"}, {"from": "ARTICLE::14", "to": "PROTEINS::TRANSFERRIN"}, {"from": "ARTICLE::14", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis", "to": "PROTEINS::IDO"}, {"from": "ARTICLE::Evaluation of Combined Cancer Markers With Lactate Dehydrogenase and Application of Machine Learning Algorithms for Differentiating Benign Disease From Malignant Ovarian Cancer", "to": "PROTEINS::LACTATE DEHYDROGENASE"}, {"from": "ARTICLE::Evaluation of Combined Cancer Markers With Lactate Dehydrogenase and Application of Machine Learning Algorithms for Differentiating Benign Disease From Malignant Ovarian Cancer", "to": "PROTEINS::HUMAN EPIDIDYMIS PROTEIN 4"}, {"from": "ARTICLE::Evaluation of Combined Cancer Markers With Lactate Dehydrogenase and Application of Machine Learning Algorithms for Differentiating Benign Disease From Malignant Ovarian Cancer", "to": "PROTEINS::CANCER ANTIGEN 125"}, {"from": "ARTICLE::Evaluation of Combined Cancer Markers With Lactate Dehydrogenase and Application of Machine Learning Algorithms for Differentiating Benign Disease From Malignant Ovarian Cancer", "to": "PROTEINS::SPECIAL AT-RICH-BINDING PROTEIN 1"}, {"from": "ARTICLE::Evaluation of Combined Cancer Markers With Lactate Dehydrogenase and Application of Machine Learning Algorithms for Differentiating Benign Disease From Malignant Ovarian Cancer", "to": "PROTEINS::3D8 ANTI-HE4 CONJUGATE"}, {"from": "ARTICLE::HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "to": "PROTEINS::CA72.4"}, {"from": "ARTICLE::HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "to": "PROTEINS::GLYCODELIN"}, {"from": "ARTICLE::HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "to": "PROTEINS::PARP"}, {"from": "ARTICLE::Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "to": "PROTEINS::B7-H4"}, {"from": "ARTICLE::Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "to": "PROTEINS::DCR3"}, {"from": "ARTICLE::Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "to": "PROTEINS::SPONDIN-2"}, {"from": "ARTICLE::Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "to": "PROTEINS::CK8"}, {"from": "ARTICLE::Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "to": "PROTEINS::CK18"}, {"from": "ARTICLE::Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "to": "PROTEINS::CK19"}, {"from": "ARTICLE::Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "to": "PROTEINS::CD45"}, {"from": "ARTICLE::Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "to": "PROTEINS::MUC-1"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "PROTEINS::GALECTIN-1"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "PROTEINS::GALECTIN-3"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "PROTEINS::GALECTIN-4"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "PROTEINS::GALECTIN-8"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "PROTEINS::GALECTIN-9"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "PROTEINS::ACAT1 PROTEIN"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "PROTEINS::KI-67 PROTEIN"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "PROTEINS::SREBP1"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "PROTEINS::TLR4"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "PROTEINS::CAVEOLIN-1"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "PROTEINS::MAPK"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "PROTEINS::ERK1"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "PROTEINS::2"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "PROTEINS::\u0392-CATENIN"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::AURKA"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::BRCA1"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::BRD4"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::ERBB3"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::CDK2"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::MTOR"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::VRK1"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::GALK1"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::HDAC4"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::STAT1"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::PIK3R1"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::GSK3B"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::MYC"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::MDM2"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "PROTEINS::HURP"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::BAIAP2L1 PROTEIN"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::BAIAP2"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::IRSP53"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::FGFR3"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::IRS1"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::IRS2"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::MAPK"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::ERK"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::SRC"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::MDM2"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::P53"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::CASPASE-3"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::PARP"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::\u0392-ACTIN"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "PROTEINS::GAPDH"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::EGFRVIII"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::UPA"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::MMP-2"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::MMP-9"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::MT1-MMP"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::CATHEPSIN B"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::MUC1"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::VEGFR"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::FGF-2"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::HSC70"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::ANNEXIN V"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::CD63"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::CD81"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::CD9"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::LAMP1"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::TSG101"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::ALIX"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::EMMPRIN"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::FASL"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::FAS LIGAND"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::TISSUE FACTOR"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::CD147"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::TISSUE TRANSGLUTAMINASE"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::HAPTOGLOBIN"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "PROTEINS::CD40"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::OSTEOPONTIN"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::SOLUBLE EGFR"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::M-CSF"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CSF-1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::MUC16"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::VEGFR-1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::NEUROPILIN-1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::ANGIOPOIETIN-1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::TIE2"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::MMP-2"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::MMP-7"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::MMP-9"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::TIMP-1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::HLA-G"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CD163"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CD68"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CD3"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CD8"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CD103"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CD24"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CD117"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::ALDH"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::ABCG2"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::KLK"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::KLK1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::KLK2"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::KLK6"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::KLK7"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::KLK15"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CD133"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CCR2"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CCL22"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::PD-L1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::PD-1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::CTLA-4"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::BEVACIZUMAB"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::NIVOLUMAB"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::AVELUMAB"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::IPILIMUMAB"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::MRE11"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::\u0393H2AX"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::HSD17B12"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::TGFBI"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::SFRP5"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::FZD4"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::DVL1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::NFATC3"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::ROCK1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::LRP5"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::AXIN1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::NKD1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::ROR1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "PROTEINS::OPCML"}, {"from": "ARTICLE::Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "to": "PROTEINS::OPN"}, {"from": "ARTICLE::Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "to": "PROTEINS::LEPTIN"}, {"from": "ARTICLE::Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "to": "PROTEINS::PROLACTIN"}, {"from": "ARTICLE::Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "to": "PROTEINS::MIF"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::CA72.4"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::CA15-3"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::CEA"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::V-CAM1"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::GLYCODELIN"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::TRANSTHYRETIN"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::OSTEOPONTIN"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::MACROPHAGE MIGRATION INHIBITORY FACTOR"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::CHI3L1"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::PEBP4"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::AGR2"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::LCAT"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::IGFBP2"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::TRANSFERRIN"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::APOLIPOPROTEIN A1"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::PROTEIN Z"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::C-REACTIVE PROTEIN"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::NY-ESO-1"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::TP53"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::TRIM-21"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::PAX-8"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::PTGFR"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::PTPRA"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "PROTEINS::IL-8"}, {"from": "ARTICLE::Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::CEA"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::CA19-9"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::CA15-3"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::CA72-4"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::IAP"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::HP-A"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::OVX-1"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::APOA-I"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::TRANSFERRIN (TF)"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::TRANSTHYRETIN (TTR)"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::H4 (INTER-A-TRYPSIN INHIBITOR HEAVY CHAIN FRAGMENT)"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::CD117"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "PROTEINS::GLYCOPROTEINS"}, {"from": "ARTICLE::Ovarian cancer biomarkers as diagnostic  \r\ntriage tests", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Ovarian cancer biomarkers as diagnostic  \r\ntriage tests", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Ovarian cancer biomarkers as diagnostic  \r\ntriage tests", "to": "PROTEINS::PREALBUMIN"}, {"from": "ARTICLE::Ovarian cancer biomarkers as diagnostic  \r\ntriage tests", "to": "PROTEINS::APOLIPOPROTEIN A-1"}, {"from": "ARTICLE::Ovarian cancer biomarkers as diagnostic  \r\ntriage tests", "to": "PROTEINS::BETA-2-MICROGLOBULIN"}, {"from": "ARTICLE::Ovarian cancer biomarkers as diagnostic  \r\ntriage tests", "to": "PROTEINS::TRANSFERRIN"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::CD24"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::SNAIL"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::PHOSPHO-AKT"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::ERK"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::PHOSPHO-ERK"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::NF-\u039aB"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::PHOSPHO-NF-\u039aB"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::TGF-\u0392"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "PROTEINS::\u0392-ACTIN"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "PROTEINS::CX3CR1"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "PROTEINS::CX3CL1"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "PROTEINS::HAVCR2"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "PROTEINS::CSF1R"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "PROTEINS::CXCR2"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "PROTEINS::CCR5"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "PROTEINS::CD86"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "PROTEINS::HLA-DMA"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "PROTEINS::HLA-DPA1"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::ALIX"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::TSG101"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::CD24"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::CD63"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::CD37"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::CD53"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::CD81"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::CD9"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::PCNA"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::TUBB3"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::APOE"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::CLDN3"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::FASN"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::ERBB2"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::L1CAM"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::LAMP2B"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::HSC70"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::FLOTILLIN"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::ANNEXIN"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::ADAM10"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::ADAM15"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::CLAUDIN-4"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::EMMPRIN"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::TGF-\u03921"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::LGALS3BP"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::PHOSPHATE ISOMERASE"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::PEROXIREDOXIN"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::GELATINOLYTIC ENZYMES"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::ALDEHYDE REDUCTASE"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::CD171"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::DNAM-1"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "PROTEINS::PVR"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::CXCR4"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::CXCL12"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::SDF-1"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::N-CADHERIN"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::VIMENTIN"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::SNAIL"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::SLUG"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::CD133"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::NANOG"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::SOX2"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::OCT-4"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::PI3K"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::MTOR"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::P-PI3K"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "PROTEINS::P-AKT"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "PROTEINS::SPARC"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "PROTEINS::TGF-\u0392"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "PROTEINS::CD31"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "PROTEINS::BEVACIZUMAB"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "PROTEINS::MCM5"}, {"from": "ARTICLE::Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis", "to": "PROTEINS::CARBOHYDRATE ANTIGEN125"}, {"from": "ARTICLE::Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis", "to": "PROTEINS::HUMAN EPIDIDYMIS PROTEIN 4"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "PROTEINS::TRANSFERRIN RECEPTOR 1 (TFR1)"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "PROTEINS::CD3"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "PROTEINS::CD8"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "PROTEINS::WT1"}, {"from": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "to": "PROTEINS::MMP-7"}, {"from": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "to": "PROTEINS::CA72-4"}, {"from": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "to": "PROTEINS::CA19-9"}, {"from": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "to": "PROTEINS::CA15-3"}, {"from": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "to": "PROTEINS::CEA"}, {"from": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "to": "PROTEINS::SVCAM"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::IL-2 RECEPTOR ALPHA"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::ALPHA-1-ANTITRYPSIN"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::C-REACTIVE PROTEIN"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::YKL-40"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::CELLULAR FIBRONECTIN"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::CA-72-4"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::PROSTASIN"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::TIMP-1"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::IL-8"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::MMP-7"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::VEGF-B"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::CALPROTECTIN"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::IGFBP-2"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::LOX-1"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::NEUROPILIN-1"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::TNFR2"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::MPIF-1"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::IL-10"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::MASPIN"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::VEGF-D"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::KALLIKREIN-7"}, {"from": "ARTICLE::ComprehensiveSerumProfilingfortheDiscoveryof\r\n EpithelialOvarianCancerBiomarkers", "to": "PROTEINS::PILIN-1"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "PROTEINS::14-3-3ETA"}, {"from": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "to": "PROTEINS::CD63"}, {"from": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "to": "PROTEINS::TSG101"}, {"from": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "to": "PROTEINS::GM130"}, {"from": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "to": "PROTEINS::GRP94"}, {"from": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "to": "PROTEINS::TGF\u03921"}, {"from": "ARTICLE::Confirmation of the utility of the  \r\nCA-125 elimination rate (KELIM) as an \r\nindicator of the chemosensitivity in \r\nadvanced-stage ovarian cancer in a \r\n\u201creal-life setting\u201d", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Confirmation of the utility of the  \r\nCA-125 elimination rate (KELIM) as an \r\nindicator of the chemosensitivity in \r\nadvanced-stage ovarian cancer in a \r\n\u201creal-life setting\u201d", "to": "PROTEINS::BEVACIZUMAB"}, {"from": "ARTICLE::DEF6 expression in ovarian carcinoma correlates with poor patient survival", "to": "PROTEINS::DEF6"}, {"from": "ARTICLE::DEF6 expression in ovarian carcinoma correlates with poor patient survival", "to": "PROTEINS::IBP"}, {"from": "ARTICLE::DEF6 expression in ovarian carcinoma correlates with poor patient survival", "to": "PROTEINS::BETA-ACTIN"}, {"from": "ARTICLE::DEF6 expression in ovarian carcinoma correlates with poor patient survival", "to": "PROTEINS::P53"}, {"from": "ARTICLE::DEF6 expression in ovarian carcinoma correlates with poor patient survival", "to": "PROTEINS::P16"}, {"from": "ARTICLE::DEF6 expression in ovarian carcinoma correlates with poor patient survival", "to": "PROTEINS::ER"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::DESMOGLEIN-2 (DSG2)"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::CLAUDIN-7"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::BETA-ACTIN"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::CDK2"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::P27"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::6D8 (DSG2-SPECIFIC ANTIBODY)"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::RECOMBINANT HUMAN DSG2 PROTEIN"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::JUNCTION OPENER (JO)"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR (CAR)"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::MATRIX METALLOPROTEINASE (MMP)"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::PAK1"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "PROTEINS::SRC"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::CK7"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::CK20"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::ER"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::PR"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::C-ERBB2"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::P-GP"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::OC125"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::MA1-90039"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::MA5-15604"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::MA1-35556"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::MA5-13304"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::MA1-410"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::MA5-13675"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "PROTEINS::MA5-13854"}, {"from": "ARTICLE::Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum", "to": "PROTEINS::ACTIN"}, {"from": "ARTICLE::Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum", "to": "PROTEINS::GELSOLIN"}, {"from": "ARTICLE::Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum", "to": "PROTEINS::ACTIN-GELSOLIN COMPLEX"}, {"from": "ARTICLE::Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum", "to": "PROTEINS::GELSOLIN1-3"}, {"from": "ARTICLE::Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum", "to": "PROTEINS::ACTIN-RHODAMINE"}, {"from": "ARTICLE::Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "to": "PROTEINS::SMRP"}, {"from": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "to": "PROTEINS::B7-H4"}, {"from": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "to": "PROTEINS::HCG"}, {"from": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "to": "PROTEINS::HCG BETA SUBUNIT"}, {"from": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "to": "PROTEINS::HCG BETA CORE FRAGMENT"}, {"from": "ARTICLE::Diagnostic role of urine human epididymis protein 4 in ovarian cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Diagnostic role of urine human epididymis protein 4 in ovarian cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "PROTEINS::CXCR4"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::A1AT"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::AACT"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::CO9"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::HPT"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::A2MG"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::ALS"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::IBP3"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::PON1"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::ITIH3"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::LG3BP"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::FIBA"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::FIBB"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::PGRP2"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::APOH"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::APOM"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::CERU"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::CO7"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::CO8G"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::CO8B"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::HGF"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::MASP1"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::SEPP1"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::LUM"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::FBLN1"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::CHLE"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::ACTG"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::IGLL5"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::IGHG2"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::GELS"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::ALDOA"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::THBG"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::HEP2"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::CD5L"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::FA10"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::KAIN"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::CBPN"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::AAL"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::CON-A"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::ECA"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::LPHA"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::SNA"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::STL"}, {"from": "ARTICLE::Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer", "to": "PROTEINS::WFA"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::ITGAV"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CXCL1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CEACAM1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::IL-10RB"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CXCL6"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CXCL11"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CXCL13"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::MK"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::FR-ALPHA"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::VEGFR-2"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::VEGFA"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::TNFRSF6B"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CTSV"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::SCF"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::TNFRSF4"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CXCL9"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CD40"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CDCP1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::RSPO3"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::TFPI-2"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::IL-10"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::IL-15RA"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::IL-8"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::IL-18R1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::IL-12B"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::IL-7"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::IL-17C"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::PVRL4"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::MMP-1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::OPG"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::ESM-1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::MSLN"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::HGF"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::FGF-21"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::STAMPB"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::METAP2"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CASP-8"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::TNFB"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CCL3"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CCL4"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CCL20"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CCL23"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CSF-1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CXCL5"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::ICOSLG"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::PD-L1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::TNFRSF9"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::LYN"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::LYPD3"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::SIRT2"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::EPHA2"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::4E-BP1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::FADD"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::AXIN1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::MCP-1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::DNER"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::ABL1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::TXLNA"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::ADAM-TS15"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::FURIN"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::EGF"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::SYND1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::S100A4"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::CD27"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::VIM"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::LAPTGF-BETA-1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "PROTEINS::IC0SLG"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "PROTEINS::DOLICHYL-PHOSPHATE BETA-GLUCOSYLTRANSFERASE"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "PROTEINS::STREPTAVIDIN"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "PROTEINS::METHYL-CPG BINDING PROTEIN"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Evaluation of HE4, CA-125, Risk of Ovarian \r\nMalignancy Algorithm (ROMA) and Risk of \r\nMalignancy Index (RMI) in the Preoperative \r\nAssessment of Patients with Adnexal Mass", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Evaluation of HE4, CA-125, Risk of Ovarian \r\nMalignancy Algorithm (ROMA) and Risk of \r\nMalignancy Index (RMI) in the Preoperative \r\nAssessment of Patients with Adnexal Mass", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "PROTEINS::HIF"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "PROTEINS::RISC"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "PROTEINS::TAQ POLYMERASE"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "PROTEINS::CD63"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "PROTEINS::P21"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "PROTEINS::SV40 LARGE T ANTIGEN"}, {"from": "ARTICLE::Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies", "to": "PROTEINS::MUC-1"}, {"from": "ARTICLE::Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies", "to": "PROTEINS::HER2"}, {"from": "ARTICLE::Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies", "to": "PROTEINS::CD45"}, {"from": "ARTICLE::Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies", "to": "PROTEINS::CD63"}, {"from": "ARTICLE::Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies", "to": "PROTEINS::CD24"}, {"from": "ARTICLE::Expression and clinical significance of survivin in ovarian cancer: A meta-analysis", "to": "PROTEINS::SURVIVIN"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::CD133"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::CD24"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::CD117"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::NOTCH-1"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::ALDH1A1"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::NANOG"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::SOX2"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::OCT3"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::4A"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::NESTIN"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::SSEA1"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::SSEA4"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::BER-EP4"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::MOC31"}, {"from": "ARTICLE::Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma", "to": "PROTEINS::CD45"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::MK"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::KLK6"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::HK11"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::CXCL13"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::FR-ALPHA"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::TNFSF14"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::FADD"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::PRSS8"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::FUR"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::IL-8"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::CXCL9"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::CXCL10"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::EZR"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::CSF1"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::NTRK3"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::EPCAM"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::ERBB2"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::ERBB3"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::ERBB4"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::VEGFR2"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::UPAR"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::TF"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::LAP.TGF-\u03921"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::PARK7"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::SELE"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::PDGF-B"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::MMP-1"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::GDF-15"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::CD40L"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::CD69"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::MUC16"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::CDH3"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::HGF"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::SCF"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::TGF-\u0391"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::VEGF-A"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::TNFR1"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::IL-1\u0391"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::CRP"}, {"from": "ARTICLE::A multiplex platform for the identification of ovarian cancer biomarkers", "to": "PROTEINS::TNF-\u0391"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::MET"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::ITGAV"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::CD147"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::L1CAM"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::ADAM10"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::EMMPRIN"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::PKR1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::STAT3"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::NF-\u039aB"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::CAV1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::MMP1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::APAF1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::TP53"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::PTEN"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::KDR"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::VEGFA"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::VEGFR"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::FASL"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::TRAIL"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::PD-L1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::PD-1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::MHC CLASS I"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::B2M"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::NKG2D"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::MICA"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::MICB"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::ULBP1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::ULBP2"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::ULBP3"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::TIM-1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::SIGLEC-10"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::HSP72"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::HSP105"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::P-GLYCOPROTEIN"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::P-GP"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::CD24"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::ACTN4"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::FOXP1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::CEBPG"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::FMNL3"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "PROTEINS::RFXAP"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "PROTEINS::CD163"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "PROTEINS::P38 MAPK"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "PROTEINS::NLRP3"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "PROTEINS::FCGR"}, {"from": "ARTICLE::HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect", "to": "PROTEINS::OSTEOPONTIN"}, {"from": "ARTICLE::HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect", "to": "PROTEINS::SOLUBLE MESOTHELIN-RELATED PROTEINS"}, {"from": "ARTICLE::HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect", "to": "PROTEINS::HUMAN BRADYKININ-RELEASING ENZYME FAMILY"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "PROTEINS::HELQ"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "PROTEINS::RPA70"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "PROTEINS::RPA32"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "PROTEINS::XPC"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "PROTEINS::XPA"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "PROTEINS::ERCC1"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "PROTEINS::RPA"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "PROTEINS::ATM"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "PROTEINS::C-ABL"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "PROTEINS::PARP"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "PROTEINS::BMP7 PROTEIN"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "PROTEINS::NOGGIN"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "PROTEINS::CALPAIN-1"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "PROTEINS::CALPAIN-2"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "PROTEINS::CALPAIN-4"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "PROTEINS::CALPASTATIN"}, {"from": "ARTICLE::High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::CALCINEURIN"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::CALCINEURIN A CATALYTIC SUBUNIT"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::CALCINEURIN B REGULATORY SUBUNIT"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::NFAT"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::C-JUN"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::DAXX"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::BAD"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::RB"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::ERK1"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::2"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::P38"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::MAPK"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::C-MYC"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::CHP2"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::CA72-4"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::CEA"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::AFP"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "PROTEINS::CA19-9"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "PROTEINS::PKP1 PROTEIN"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "PROTEINS::PKP2 PROTEIN"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "PROTEINS::PKP3 PROTEIN"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::CYP2E1"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::COX-2"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::5-LOX"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::SRC FAMILY KINASES"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::MAPK"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::UROKINASE-TYPE PLASMINOGEN ACTIVATOR"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::MMPS"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::IL-8"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::CXCL12"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::CXCR4"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::CYCLIN D1"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::YAP"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "PROTEINS::DGK\u0391"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::IL-1RA"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::IL-6"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::DKK-1"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::UPA"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::E-CAD"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::ERBB2"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::SLPI"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::LCN2"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::MSLN"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "PROTEINS::OPN"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::HGF"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::MAPK13"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::OGG1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::PLA2R1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::SCGB1A1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::SIGMAR1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::SLC7A11"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::TRPM2"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::DUOX1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::FOXO1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::GPR37"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::IL18BP"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::ARL6IP5"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::CD38"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::JAK2"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::MELK"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::MICB"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::NAPRT"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::NDUFB4"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::SIRPA"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::BRCA1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::TP53"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::TTN"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::DNAH3"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::DNAH5"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::DNAH9"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::DNAH10"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::DNAH17"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::LRP2"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::LRP1B"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::MGA"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::VCAN"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::ZFHX3"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::PCLO"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::LCT"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::ARID1B"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::AIM1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::PD-1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::PD-L1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::PD-L2"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::B7-H3"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::CD27"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::CD58"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::CD70"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::CD86"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::CD40"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::CD270"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::TIGIT"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::LAG3"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::TIM-3"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::CTLA4"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::ICOS"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::IDO1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::CD276"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::HAVCR2"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::HVEM"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::PDCD1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::PDCD1LG2"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "PROTEINS::CD274"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::COL3A1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::GPR158"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::PITHD1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::COL11A1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::MTUS1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::EHD3"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::FRMPD2"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::GABRP"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::GID4"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::GRM5"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::IGHG1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::JCHAIN"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::KIF26B"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::MAP7D2"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::MTRNR2L1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::MUC15"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::PTEN"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::RTKN2"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::SLC9A4"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::SMYD2"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::TRIM71"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::TRIO"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::TTK"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::VNN1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::ARHGAP21"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::ARMC3"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::C7"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::CDH18"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "PROTEINS::CES3"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::CHI3L1"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::PEBP4"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::AGR2"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::LRG1"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::DNAH17"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::FSTL1"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::SLPI"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::PAEP"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::GLYCODELIN"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::A1AT"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::CRP"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::HP"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::ORM1"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::ORM2"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::SAA1"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "PROTEINS::YKL-40"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::MUC16"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::VEGFR"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::ERBB2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::ERBB3"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::ERBB4"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::NOTCH1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::HGF"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::IGF1R"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::PDGF"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::PDGFRB"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::FGFR1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::TNF"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::IL6"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::IL6R"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::IL8"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::CXCL8"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::BCL2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::BCL2L1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::MCL1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::XIAP"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::SURVIVIN"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::PARP1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::CDKN1A"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::BIK"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::MMP2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::MMP9"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::CLDN3"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::CLDN4"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::CLDN5"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::OPN"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::POSTN"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::MSLN"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::LPAR2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::LPAR3"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::FOLR1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::AGR2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::TTR"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::CRP"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::APOA1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::UPA"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::PLAU"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::UPAR"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::BCLXL"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::BCLW"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::GSTP1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::P-GLYCOPROTEIN"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::ABCB1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::HDAC1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::SNAI1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::SNAI2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::SLUG"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::CD44"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::NF-KB"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::STAT3"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::JAK1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::JAK2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::MTOR"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::AKT1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::KRAS"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::KDR"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::ERK"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::YAP"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "PROTEINS::FR\u0391"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "PROTEINS::KALLIKREIN-5"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "PROTEINS::KALLIKREIN-7"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "PROTEINS::KALLIKREIN-11"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "PROTEINS::KALLIKREIN-8"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "PROTEINS::KALLIKREIN-4"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "PROTEINS::KALLIKREIN-6"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "PROTEINS::KALLIKREIN-15"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "PROTEINS::KALLIKREIN-3"}, {"from": "ARTICLE::Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "to": "PROTEINS::EUKARYOTIC TRANSLATION INITIATION FACTOR 2B SUBUNIT 5"}, {"from": "ARTICLE::Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "to": "PROTEINS::MESOTHELIN"}, {"from": "ARTICLE::Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "to": "PROTEINS::SMRP"}, {"from": "ARTICLE::Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "to": "PROTEINS::MEGAKARYOCYTE POTENTIATING FACTOR"}, {"from": "ARTICLE::Metabonomics study of the serum from ovarian cancer patients", "to": "PROTEINS::APOA4 PROTEIN"}, {"from": "ARTICLE::Metabonomics study of the serum from ovarian cancer patients", "to": "PROTEINS::AMPK"}, {"from": "ARTICLE::Metabonomics study of the serum from ovarian cancer patients", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::LEPTIN"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::PROLACTIN"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::OSTEOPONTIN"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::IGF-II"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::\u0392-TUBULIN III"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::MMP-3"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::P53"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::ERBB2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::HER2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::ERBB4"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::VEGFR2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::HMGA2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::ZEB1"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::ZEB2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::PTEN"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::PDCD4"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::BCL2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::MTOR"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::P38\u0391"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::JAK"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::STAT3"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::SMAD2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::SMAD3"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::SMAD7"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::NODAL"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::ALK7"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::IGF2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::PDGFRA"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::MCL1"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::AGO2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::DROSHA"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::DICER1"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::DGCR8"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::XPO5"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "PROTEINS::TRBP"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "PROTEINS::ADAM12"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "PROTEINS::ADAM12-L"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "PROTEINS::ADAM12-S"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "PROTEINS::SV40 LARGE T-ANTIGEN"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "PROTEINS::TGF\u03921"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "PROTEINS::ADAM12 PROTEIN"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::DICER"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::DROSHA"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::DGCR8"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::EXPORTIN-5"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::AGO1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::AGO2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::AGO3"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::AGO4"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::SMAD2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::ZEB1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::ZEB2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::TGFBR1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::VEGFA"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::BAX"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::BCL-2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::MAPK1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::C-MYC"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::HMGA2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::TP63"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::HIF-1\u0391"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::HIF-3\u0391"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::FHIT"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::ZBTB4"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::CDC42"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::PAK1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::GSK3\u0392"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::CCND1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::ERBB2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::MUC16"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::MYB"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::SOX4"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "PROTEINS::KIF4A"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "PROTEINS::YKL-40"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "PROTEINS::MCL-1"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "PROTEINS::BCL-2"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "PROTEINS::BAK"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "PROTEINS::BAX"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "PROTEINS::\u0391-TUBULIN"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "PROTEINS::HE4"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "PROTEINS::INTEGRIN BETA-5"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "PROTEINS::ESTROGEN RECEPTOR-\u0391 (ER-\u0391)"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "PROTEINS::EGF"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "PROTEINS::VEGF"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "PROTEINS::INSULIN"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "PROTEINS::HE4 ANTIBODY"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "PROTEINS::INTEGRIN \u03925 MONOCLONAL ANTIBODY"}, {"from": "ARTICLE::Overexpression of ICAM-1 Predicts Poor Survival in\r\n High-Grade Serous Ovarian Carcinoma: A Study Based on\r\n TCGAandGEODatabases and Tissue Microarray", "to": "PROTEINS::ICAM-1"}, {"from": "ARTICLE::Overexpression of ICAM-1 Predicts Poor Survival in\r\n High-Grade Serous Ovarian Carcinoma: A Study Based on\r\n TCGAandGEODatabases and Tissue Microarray", "to": "PROTEINS::CD54"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "PROTEINS::PD-1"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "PROTEINS::PD-L1"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "PROTEINS::PD-L2"}, {"from": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "to": "PROTEINS::REDD1"}, {"from": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "to": "PROTEINS::MTORC1"}, {"from": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "to": "PROTEINS::TSC1"}, {"from": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "to": "PROTEINS::TSC2"}, {"from": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "to": "PROTEINS::HIF1"}, {"from": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "to": "PROTEINS::AKT"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD8 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD14 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD1 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD2 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD3 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD4 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD5 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD6 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD7 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD9 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD10 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD11 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD12 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMD13 PROTEIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMC1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMC2"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMC3"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMC4"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMC5"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PSMC6"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::GANKYRIN"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::GRP78"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::HER2"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PKM2"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::E2F1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::STAT3"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::RB1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::SOX2"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::AKT1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::MMP9"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::IDO1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::IL10RB"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PVR"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::TNFRSF4"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::MICB"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::CD48"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::AQN1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::ATG7"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::ACVR1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::BMP6"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::PKM"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::ERBB2"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::HLA-A"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::HLA-C"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::B2M"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::TAP1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::TP53"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "PROTEINS::NFE2L2"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::PKC\u0393"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::PKC\u0391"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::PKC\u0392"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::PKC\u0395"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::CONNEXIN 43"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::CX43"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::CXCR4"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::IP3R"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::CX26"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::CX32"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::VEGFR"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::FGFR"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::A24S"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "PROTEINS::K359R"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "PROTEINS::PEROXIREDOXIN-1 (PRDX-1)"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "PROTEINS::ESTROGEN RECEPTOR (ER)"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "PROTEINS::ESTROGEN RECEPTOR ALPHA (ER\u0391)"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "PROTEINS::ANDROGEN RECEPTOR (AR)"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "PROTEINS::TLR4"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "PROTEINS::NF-\u039aB"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "PROTEINS::VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "PROTEINS::ASK1"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "PROTEINS::P21"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "PROTEINS::CA-125"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "PROTEINS::DNA POLYMERASE"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::APOC1"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::CD163"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::CD206"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::IL10"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::ARG1"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::GAPDH"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::HAVCR2"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::AIF1"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::LILRB4"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::APOE"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::TYROBP"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::FCER1G"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::CD48"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::LST1"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::GMFG"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::CD80"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::CD86"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::KEAP1"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::NRF2"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "PROTEINS::ABI3"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::PLASMA GELSOLIN (PGSN)"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::GELSOLIN (GSN)"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::SEV-PGSN"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::CD9"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::CD63"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::CD81"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::GAPDH"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::CALNEXIN"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::DNMT1"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::DNGR-1"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::CD8"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "PROTEINS::CD4"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "PROTEINS::PARP"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "PROTEINS::ERBB2"}, {"from": "ARTICLE::Prognostic Significance of CA125 Dynamic \r\nChange for Progression Free Survival in Patients \r\nwith Epithelial Ovarian Carcinoma", "to": "PROTEINS::CA125"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::TGF-\u03921"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::TGF-\u03922"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::TGF-\u03923"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::TGF-\u03924"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::SMAD"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::MAPK"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::PI3K"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::RAS"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::N-CADHERIN"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::MMP2"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::NF-\u039aB"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::LKB1"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "PROTEINS::HIF-1\u0391"}, {"from": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "to": "PROTEINS::NRF2"}, {"from": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "to": "PROTEINS::KEAP1"}, {"from": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "to": "PROTEINS::E-CADHERIN"}, {"from": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "to": "PROTEINS::P53"}, {"from": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "to": "PROTEINS::P16"}, {"from": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "to": "PROTEINS::ER"}, {"from": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "to": "PROTEINS::P62"}, {"from": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "to": "PROTEINS::LC3"}, {"from": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "to": "PROTEINS::BECLIN1"}, {"from": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "to": "PROTEINS::VPS34"}, {"from": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "to": "PROTEINS::BCL-2"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "PROTEINS::PRC2"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "PROTEINS::LSD1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::EGFR"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::MEK1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::2"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::ERK1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::N-CADHERIN"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::VIMENTIN"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::SNAIL"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::GAPDH"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::CD9"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::ICAM1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::HSP70"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::CALNEXIN"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::PHOSPHO-EGFR TYR1068"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::COL6A1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::LAMB1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::PLAU"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::TGFB1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::TGFBI"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "PROTEINS::NOX ENZYMES"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "PROTEINS::FASN"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "PROTEINS::L1CAM"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "PROTEINS::TSG101"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "PROTEINS::GAPDH"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "PROTEINS::\u0392-ACTIN"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "PROTEINS::\u0392-TUBULIN"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "PROTEINS::CD63"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "PROTEINS::CD9"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "PROTEINS::LPL"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "PROTEINS::ALIX"}, {"from": "ARTICLE::Protocol for identifying metabolite biomarkers in patient uterine fluid for early ovarian cancer detection", "to": "PROTEINS::CA125 (CANCER ANTIGEN 125)"}, {"from": "ARTICLE::Protocol for identifying metabolite biomarkers in patient uterine fluid for early ovarian cancer detection", "to": "PROTEINS::HE4 (HUMAN EPIDIDYMIS PROTEIN 4)"}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {"interaction": {"hover": false, "tooltipDelay": 999999}};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  
                      network.on("stabilizationProgress", function(params) {
                          document.getElementById('loadingBar').removeAttribute("style");
                          var maxWidth = 496;
                          var minWidth = 20;
                          var widthFactor = params.iterations/params.total;
                          var width = Math.max(minWidth,maxWidth * widthFactor);
                          document.getElementById('bar').style.width = width + 'px';
                          document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';
                      });
                      network.once("stabilizationIterationsDone", function() {
                          document.getElementById('text').innerHTML = '100%';
                          document.getElementById('bar').style.width = '496px';
                          document.getElementById('loadingBar').style.opacity = 0;
                          // really clean the dom element
                          setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);
                      });
                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>